Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF CELL DIFFERENTIATION |
465 |
1492 |
2.2e-49 |
1.024e-45 |
2 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
501 |
1672 |
8.095e-48 |
1.883e-44 |
3 |
NEUROGENESIS |
439 |
1402 |
4.409e-47 |
6.838e-44 |
4 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
283 |
788 |
4.169e-42 |
3.88e-39 |
5 |
CIRCULATORY SYSTEM DEVELOPMENT |
283 |
788 |
4.169e-42 |
3.88e-39 |
6 |
TISSUE DEVELOPMENT |
451 |
1518 |
9.899e-42 |
7.677e-39 |
7 |
CELL DEVELOPMENT |
429 |
1426 |
4.426e-41 |
2.942e-38 |
8 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
272 |
771 |
7.322e-39 |
4.259e-36 |
9 |
BIOLOGICAL ADHESION |
329 |
1032 |
1.043e-36 |
5.395e-34 |
10 |
REGULATION OF CELL DEVELOPMENT |
280 |
836 |
2.238e-35 |
1.041e-32 |
11 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
322 |
1021 |
6.622e-35 |
2.801e-32 |
12 |
VASCULATURE DEVELOPMENT |
187 |
469 |
8.574e-35 |
3.325e-32 |
13 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
349 |
1142 |
9.623e-35 |
3.444e-32 |
14 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
404 |
1395 |
1.845e-34 |
6.132e-32 |
15 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
458 |
1656 |
7.273e-34 |
2.256e-31 |
16 |
RESPONSE TO ENDOGENOUS STIMULUS |
412 |
1450 |
3.937e-33 |
1.145e-30 |
17 |
NEURON DIFFERENTIATION |
279 |
874 |
3.201e-31 |
8.762e-29 |
18 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
474 |
1791 |
4.179e-30 |
1.08e-27 |
19 |
BLOOD VESSEL MORPHOGENESIS |
150 |
364 |
6.194e-30 |
1.517e-27 |
20 |
INTRACELLULAR SIGNAL TRANSDUCTION |
427 |
1572 |
1.282e-29 |
2.984e-27 |
21 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
500 |
1929 |
1.821e-29 |
3.7e-27 |
22 |
ORGAN MORPHOGENESIS |
267 |
841 |
1.829e-29 |
3.7e-27 |
23 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
305 |
1008 |
1.702e-29 |
3.7e-27 |
24 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
261 |
823 |
9.969e-29 |
1.933e-26 |
25 |
POSITIVE REGULATION OF CELL COMMUNICATION |
415 |
1532 |
1.713e-28 |
3.189e-26 |
26 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
359 |
1275 |
5.764e-28 |
1.032e-25 |
27 |
LOCOMOTION |
324 |
1114 |
6.617e-28 |
1.14e-25 |
28 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
270 |
872 |
7.302e-28 |
1.213e-25 |
29 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
241 |
750 |
1.734e-27 |
2.783e-25 |
30 |
REGULATION OF NEURON DIFFERENTIATION |
194 |
554 |
2.147e-27 |
3.33e-25 |
31 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
287 |
957 |
4.54e-27 |
6.814e-25 |
32 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
374 |
1360 |
5.621e-27 |
8.174e-25 |
33 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
427 |
1618 |
9.675e-27 |
1.364e-24 |
34 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
249 |
801 |
5.204e-26 |
7.122e-24 |
35 |
REGULATION OF CELL PROLIFERATION |
399 |
1496 |
6.423e-26 |
8.539e-24 |
36 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
333 |
1192 |
2.77e-25 |
3.58e-23 |
37 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
179 |
513 |
3.838e-25 |
4.827e-23 |
38 |
REGULATION OF TRANSPORT |
459 |
1804 |
4.397e-25 |
5.384e-23 |
39 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
245 |
799 |
1.151e-24 |
1.373e-22 |
40 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
466 |
1848 |
1.38e-24 |
1.605e-22 |
41 |
TUBE DEVELOPMENT |
187 |
552 |
1.752e-24 |
1.988e-22 |
42 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
370 |
1381 |
2.11e-24 |
2.337e-22 |
43 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
219 |
689 |
2.394e-24 |
2.574e-22 |
44 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
285 |
983 |
2.434e-24 |
2.574e-22 |
45 |
MUSCLE STRUCTURE DEVELOPMENT |
157 |
432 |
2.868e-24 |
2.966e-22 |
46 |
EPITHELIUM DEVELOPMENT |
276 |
945 |
4.136e-24 |
4.135e-22 |
47 |
HEAD DEVELOPMENT |
223 |
709 |
4.177e-24 |
4.135e-22 |
48 |
HEART DEVELOPMENT |
165 |
466 |
4.91e-24 |
4.76e-22 |
49 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
397 |
1518 |
5.129e-24 |
4.87e-22 |
50 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
295 |
1036 |
7.952e-24 |
7.255e-22 |
51 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
295 |
1036 |
7.952e-24 |
7.255e-22 |
52 |
CELL MOTILITY |
250 |
835 |
1.57e-23 |
1.379e-21 |
53 |
LOCALIZATION OF CELL |
250 |
835 |
1.57e-23 |
1.379e-21 |
54 |
CELLULAR COMPONENT MORPHOGENESIS |
263 |
900 |
4.897e-23 |
4.219e-21 |
55 |
REGULATION OF CELL PROJECTION ORGANIZATION |
185 |
558 |
5.194e-23 |
4.394e-21 |
56 |
SKELETAL SYSTEM DEVELOPMENT |
160 |
455 |
5.524e-23 |
4.59e-21 |
57 |
NEURON DEVELOPMENT |
215 |
687 |
5.786e-23 |
4.723e-21 |
58 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
148 |
408 |
7.515e-23 |
6.029e-21 |
59 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
257 |
876 |
8.65e-23 |
6.822e-21 |
60 |
REGULATION OF SYSTEM PROCESS |
172 |
507 |
1.123e-22 |
8.707e-21 |
61 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
430 |
1710 |
2.178e-22 |
1.661e-20 |
62 |
NEURON PROJECTION DEVELOPMENT |
180 |
545 |
3.292e-22 |
2.471e-20 |
63 |
POSITIVE REGULATION OF TRANSPORT |
268 |
936 |
4.607e-22 |
3.402e-20 |
64 |
REGULATION OF CELL MORPHOGENESIS |
181 |
552 |
6.184e-22 |
4.496e-20 |
65 |
REGULATION OF MAPK CASCADE |
205 |
660 |
1.672e-21 |
1.197e-19 |
66 |
PROTEIN PHOSPHORYLATION |
268 |
944 |
1.722e-21 |
1.214e-19 |
67 |
REGULATION OF ION TRANSPORT |
189 |
592 |
2.233e-21 |
1.551e-19 |
68 |
ANGIOGENESIS |
115 |
293 |
3.622e-21 |
2.461e-19 |
69 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
440 |
1784 |
3.649e-21 |
2.461e-19 |
70 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
160 |
472 |
3.929e-21 |
2.611e-19 |
71 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
192 |
609 |
5.218e-21 |
3.42e-19 |
72 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
126 |
337 |
6.37e-21 |
4.117e-19 |
73 |
TISSUE MORPHOGENESIS |
174 |
533 |
6.711e-21 |
4.278e-19 |
74 |
RESPONSE TO WOUNDING |
181 |
563 |
6.977e-21 |
4.387e-19 |
75 |
RESPONSE TO HORMONE |
254 |
893 |
1.599e-20 |
9.918e-19 |
76 |
POSITIVE REGULATION OF GENE EXPRESSION |
427 |
1733 |
1.909e-20 |
1.169e-18 |
77 |
CELL PROJECTION ORGANIZATION |
255 |
902 |
3.254e-20 |
1.966e-18 |
78 |
REGULATION OF HYDROLASE ACTIVITY |
344 |
1327 |
3.834e-20 |
2.287e-18 |
79 |
POSITIVE REGULATION OF LOCOMOTION |
145 |
420 |
4.337e-20 |
2.554e-18 |
80 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
255 |
905 |
5.266e-20 |
3.063e-18 |
81 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
377 |
1492 |
5.388e-20 |
3.095e-18 |
82 |
POSITIVE REGULATION OF MAPK CASCADE |
156 |
470 |
1.251e-19 |
7.1e-18 |
83 |
EMBRYO DEVELOPMENT |
251 |
894 |
1.754e-19 |
9.834e-18 |
84 |
REGULATION OF GTPASE ACTIVITY |
201 |
673 |
5.933e-19 |
3.286e-17 |
85 |
REGULATION OF MEMBRANE POTENTIAL |
123 |
343 |
9.816e-19 |
5.373e-17 |
86 |
REGULATION OF KINASE ACTIVITY |
223 |
776 |
1.075e-18 |
5.819e-17 |
87 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
299 |
1135 |
1.262e-18 |
6.748e-17 |
88 |
NEURON PROJECTION MORPHOGENESIS |
137 |
402 |
1.705e-18 |
9.017e-17 |
89 |
REGULATION OF CELL DEATH |
367 |
1472 |
1.867e-18 |
9.762e-17 |
90 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
271 |
1004 |
1.948e-18 |
1.007e-16 |
91 |
REGULATION OF BLOOD CIRCULATION |
110 |
295 |
2.484e-18 |
1.27e-16 |
92 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
145 |
437 |
2.571e-18 |
1.273e-16 |
93 |
RESPONSE TO GROWTH FACTOR |
154 |
475 |
2.568e-18 |
1.273e-16 |
94 |
UROGENITAL SYSTEM DEVELOPMENT |
111 |
299 |
2.557e-18 |
1.273e-16 |
95 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
432 |
1805 |
3.106e-18 |
1.521e-16 |
96 |
REGULATION OF METAL ION TRANSPORT |
117 |
325 |
4.918e-18 |
2.384e-16 |
97 |
RESPONSE TO LIPID |
245 |
888 |
5.288e-18 |
2.537e-16 |
98 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
251 |
917 |
5.957e-18 |
2.828e-16 |
99 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
112 |
306 |
6.163e-18 |
2.897e-16 |
100 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
300 |
1152 |
6.353e-18 |
2.956e-16 |
101 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
168 |
541 |
8.371e-18 |
3.819e-16 |
102 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
168 |
541 |
8.371e-18 |
3.819e-16 |
103 |
REGULATION OF HEART CONTRACTION |
89 |
221 |
1.602e-17 |
7.238e-16 |
104 |
BEHAVIOR |
160 |
516 |
6.022e-17 |
2.694e-15 |
105 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
125 |
368 |
7.347e-17 |
3.256e-15 |
106 |
CONNECTIVE TISSUE DEVELOPMENT |
80 |
194 |
1.346e-16 |
5.909e-15 |
107 |
RESPONSE TO NITROGEN COMPOUND |
234 |
859 |
1.56e-16 |
6.729e-15 |
108 |
MUSCLE SYSTEM PROCESS |
103 |
282 |
1.562e-16 |
6.729e-15 |
109 |
EMBRYONIC MORPHOGENESIS |
164 |
539 |
1.729e-16 |
7.38e-15 |
110 |
RESPONSE TO ABIOTIC STIMULUS |
268 |
1024 |
2.215e-16 |
9.371e-15 |
111 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
108 |
304 |
2.769e-16 |
1.161e-14 |
112 |
TAXIS |
146 |
464 |
3.586e-16 |
1.49e-14 |
113 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
166 |
552 |
3.755e-16 |
1.546e-14 |
114 |
POSITIVE REGULATION OF KINASE ACTIVITY |
150 |
482 |
4.079e-16 |
1.665e-14 |
115 |
SINGLE ORGANISM BEHAVIOR |
127 |
384 |
4.453e-16 |
1.802e-14 |
116 |
WOUND HEALING |
147 |
470 |
5.033e-16 |
2.019e-14 |
117 |
CELL CELL ADHESION |
178 |
608 |
5.571e-16 |
2.216e-14 |
118 |
TUBE MORPHOGENESIS |
112 |
323 |
5.74e-16 |
2.263e-14 |
119 |
MUSCLE TISSUE DEVELOPMENT |
100 |
275 |
6.055e-16 |
2.348e-14 |
120 |
POSITIVE REGULATION OF ION TRANSPORT |
90 |
236 |
6.021e-16 |
2.348e-14 |
121 |
CIRCULATORY SYSTEM PROCESS |
122 |
366 |
8.736e-16 |
3.36e-14 |
122 |
MORPHOGENESIS OF AN EPITHELIUM |
130 |
400 |
9.415e-16 |
3.591e-14 |
123 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
135 |
422 |
1.093e-15 |
4.103e-14 |
124 |
PHOSPHORYLATION |
307 |
1228 |
1.09e-15 |
4.103e-14 |
125 |
SENSORY ORGAN DEVELOPMENT |
151 |
493 |
1.496e-15 |
5.57e-14 |
126 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
452 |
1977 |
2.394e-15 |
8.841e-14 |
127 |
MUSCLE CELL DIFFERENTIATION |
89 |
237 |
2.601e-15 |
9.529e-14 |
128 |
POSITIVE REGULATION OF CELL PROLIFERATION |
220 |
814 |
3.342e-15 |
1.215e-13 |
129 |
REGULATION OF CELL ADHESION |
180 |
629 |
4.168e-15 |
1.503e-13 |
130 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
105 |
303 |
4.916e-15 |
1.76e-13 |
131 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
152 |
505 |
6.264e-15 |
2.225e-13 |
132 |
EMBRYONIC ORGAN DEVELOPMENT |
129 |
406 |
8.503e-15 |
2.997e-13 |
133 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
150 |
498 |
8.872e-15 |
3.104e-13 |
134 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
86 |
232 |
1.834e-14 |
6.37e-13 |
135 |
GROWTH |
129 |
410 |
1.944e-14 |
6.699e-13 |
136 |
ACTIN FILAMENT BASED PROCESS |
138 |
450 |
2.273e-14 |
7.778e-13 |
137 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
99 |
285 |
2.49e-14 |
8.455e-13 |
138 |
REGULATION OF MUSCLE SYSTEM PROCESS |
76 |
195 |
2.862e-14 |
9.65e-13 |
139 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
97 |
278 |
3.313e-14 |
1.109e-12 |
140 |
CELLULAR RESPONSE TO LIPID |
139 |
457 |
3.737e-14 |
1.242e-12 |
141 |
RESPONSE TO EXTERNAL STIMULUS |
416 |
1821 |
4.368e-14 |
1.441e-12 |
142 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
60 |
138 |
4.971e-14 |
1.629e-12 |
143 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
84 |
229 |
7.313e-14 |
2.38e-12 |
144 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
131 |
426 |
8.315e-14 |
2.687e-12 |
145 |
RESPONSE TO OXYGEN LEVELS |
104 |
311 |
9.277e-14 |
2.977e-12 |
146 |
DEVELOPMENTAL GROWTH |
109 |
333 |
1.177e-13 |
3.75e-12 |
147 |
NEGATIVE REGULATION OF LOCOMOTION |
92 |
263 |
1.275e-13 |
4.035e-12 |
148 |
CELL ACTIVATION |
162 |
568 |
1.392e-13 |
4.377e-12 |
149 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
67 |
167 |
1.887e-13 |
5.893e-12 |
150 |
BONE DEVELOPMENT |
64 |
156 |
1.927e-13 |
5.978e-12 |
151 |
SECOND MESSENGER MEDIATED SIGNALING |
65 |
160 |
2.162e-13 |
6.661e-12 |
152 |
RESPONSE TO MECHANICAL STIMULUS |
78 |
210 |
2.651e-13 |
8.115e-12 |
153 |
CELL PART MORPHOGENESIS |
175 |
633 |
2.986e-13 |
9.082e-12 |
154 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
177 |
643 |
3.295e-13 |
9.954e-12 |
155 |
SENSORY ORGAN MORPHOGENESIS |
85 |
239 |
3.816e-13 |
1.146e-11 |
156 |
CARTILAGE DEVELOPMENT |
61 |
147 |
3.852e-13 |
1.149e-11 |
157 |
REGULATION OF CELLULAR LOCALIZATION |
306 |
1277 |
4.029e-13 |
1.194e-11 |
158 |
FOREBRAIN DEVELOPMENT |
113 |
357 |
5.238e-13 |
1.543e-11 |
159 |
MULTICELLULAR ORGANISMAL SIGNALING |
54 |
123 |
5.59e-13 |
1.627e-11 |
160 |
RESPIRATORY SYSTEM DEVELOPMENT |
74 |
197 |
5.595e-13 |
1.627e-11 |
161 |
POSITIVE REGULATION OF CELL DEATH |
168 |
605 |
6.015e-13 |
1.738e-11 |
162 |
REGULATION OF TRANSFERASE ACTIVITY |
239 |
946 |
6.352e-13 |
1.824e-11 |
163 |
SYNAPSE ORGANIZATION |
60 |
145 |
6.942e-13 |
1.982e-11 |
164 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
102 |
312 |
7.861e-13 |
2.23e-11 |
165 |
RESPONSE TO STEROID HORMONE |
144 |
497 |
8.747e-13 |
2.467e-11 |
166 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
138 |
470 |
8.926e-13 |
2.502e-11 |
167 |
STRIATED MUSCLE CELL DIFFERENTIATION |
67 |
173 |
1.338e-12 |
3.719e-11 |
168 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
201 |
767 |
1.343e-12 |
3.719e-11 |
169 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
76 |
208 |
1.403e-12 |
3.862e-11 |
170 |
REGULATION OF MAP KINASE ACTIVITY |
103 |
319 |
1.441e-12 |
3.943e-11 |
171 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
195 |
740 |
1.711e-12 |
4.655e-11 |
172 |
REGULATION OF BODY FLUID LEVELS |
145 |
506 |
1.836e-12 |
4.967e-11 |
173 |
REGULATION OF VASCULATURE DEVELOPMENT |
82 |
233 |
1.874e-12 |
5.041e-11 |
174 |
REGULATION OF GROWTH |
172 |
633 |
2.377e-12 |
6.356e-11 |
175 |
NEGATIVE REGULATION OF TRANSPORT |
134 |
458 |
2.539e-12 |
6.751e-11 |
176 |
REGULATION OF HEART RATE |
42 |
86 |
2.776e-12 |
7.34e-11 |
177 |
EPITHELIAL CELL DIFFERENTIATION |
142 |
495 |
2.861e-12 |
7.521e-11 |
178 |
COGNITION |
86 |
251 |
2.902e-12 |
7.586e-11 |
179 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
129 |
437 |
3.294e-12 |
8.561e-11 |
180 |
MUSCLE ORGAN DEVELOPMENT |
92 |
277 |
3.821e-12 |
9.878e-11 |
181 |
REGULATION OF HOMEOSTATIC PROCESS |
131 |
447 |
3.93e-12 |
1.01e-10 |
182 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
98 |
303 |
4.488e-12 |
1.147e-10 |
183 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
72 |
197 |
5.332e-12 |
1.356e-10 |
184 |
REGULATION OF ION HOMEOSTASIS |
73 |
201 |
5.411e-12 |
1.368e-10 |
185 |
EMBRYONIC ORGAN MORPHOGENESIS |
92 |
279 |
6.029e-12 |
1.516e-10 |
186 |
REGULATION OF OSSIFICATION |
67 |
178 |
6.195e-12 |
1.55e-10 |
187 |
STEM CELL DIFFERENTIATION |
70 |
190 |
6.799e-12 |
1.692e-10 |
188 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
134 |
465 |
8.329e-12 |
2.061e-10 |
189 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
14 |
14 |
9.905e-12 |
2.439e-10 |
190 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
80 |
232 |
1.145e-11 |
2.803e-10 |
191 |
REGULATION OF EPITHELIAL CELL MIGRATION |
63 |
166 |
1.735e-11 |
4.226e-10 |
192 |
NEGATIVE REGULATION OF CELL DEATH |
218 |
872 |
2.02e-11 |
4.895e-10 |
193 |
IMMUNE SYSTEM DEVELOPMENT |
158 |
582 |
2.043e-11 |
4.925e-10 |
194 |
MESENCHYME DEVELOPMENT |
69 |
190 |
2.056e-11 |
4.932e-10 |
195 |
REGULATION OF TRANSPORTER ACTIVITY |
71 |
198 |
2.09e-11 |
4.987e-10 |
196 |
HEMOSTASIS |
98 |
311 |
2.424e-11 |
5.755e-10 |
197 |
CELLULAR RESPONSE TO ACID CHEMICAL |
65 |
175 |
2.515e-11 |
5.939e-10 |
198 |
SINGLE ORGANISM CELL ADHESION |
131 |
459 |
2.951e-11 |
6.936e-10 |
199 |
VASCULOGENESIS |
32 |
59 |
3.107e-11 |
7.265e-10 |
200 |
MUSCLE CONTRACTION |
79 |
233 |
3.987e-11 |
9.276e-10 |
201 |
REGULATION OF CELL SUBSTRATE ADHESION |
64 |
173 |
4.359e-11 |
1.009e-09 |
202 |
CHEMICAL HOMEOSTASIS |
217 |
874 |
4.461e-11 |
1.028e-09 |
203 |
NEURON PROJECTION GUIDANCE |
72 |
205 |
4.603e-11 |
1.055e-09 |
204 |
REGULATION OF PROTEIN LOCALIZATION |
232 |
950 |
5.11e-11 |
1.166e-09 |
205 |
REGULATION OF DEVELOPMENTAL GROWTH |
92 |
289 |
5.322e-11 |
1.208e-09 |
206 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
62 |
166 |
5.491e-11 |
1.24e-09 |
207 |
REGULATION OF RESPONSE TO WOUNDING |
120 |
413 |
5.782e-11 |
1.3e-09 |
208 |
REGULATION OF MUSCLE CONTRACTION |
57 |
147 |
5.848e-11 |
1.308e-09 |
209 |
POSITIVE REGULATION OF ENDOCYTOSIS |
48 |
114 |
6.502e-11 |
1.448e-09 |
210 |
CYTOSKELETON ORGANIZATION |
209 |
838 |
6.733e-11 |
1.492e-09 |
211 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
56 |
144 |
7.516e-11 |
1.658e-09 |
212 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
72 |
207 |
7.68e-11 |
1.686e-09 |
213 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
150 |
554 |
8.19e-11 |
1.789e-09 |
214 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
163 |
616 |
8.512e-11 |
1.851e-09 |
215 |
CELL CELL SIGNALING |
194 |
767 |
9.431e-11 |
2.041e-09 |
216 |
REGULATION OF HEART RATE BY CARDIAC CONDUCTION |
21 |
30 |
9.569e-11 |
2.061e-09 |
217 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
89 |
279 |
9.679e-11 |
2.075e-09 |
218 |
MESENCHYMAL CELL DIFFERENTIATION |
53 |
134 |
1.146e-10 |
2.446e-09 |
219 |
REGULATION OF RESPONSE TO STRESS |
331 |
1468 |
1.262e-10 |
2.682e-09 |
220 |
REGULATION OF CALCIUM ION TRANSPORT |
72 |
209 |
1.268e-10 |
2.683e-09 |
221 |
IMMUNE SYSTEM PROCESS |
428 |
1984 |
1.285e-10 |
2.704e-09 |
222 |
RHYTHMIC PROCESS |
93 |
298 |
1.391e-10 |
2.915e-09 |
223 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
162 |
616 |
1.61e-10 |
3.36e-09 |
224 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
225 |
926 |
1.669e-10 |
3.466e-09 |
225 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
32 |
62 |
1.734e-10 |
3.586e-09 |
226 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
67 |
190 |
1.758e-10 |
3.62e-09 |
227 |
EYE DEVELOPMENT |
99 |
326 |
1.96e-10 |
4.018e-09 |
228 |
CARDIAC CONDUCTION |
38 |
82 |
2.144e-10 |
4.376e-09 |
229 |
REGULATION OF CYTOPLASMIC TRANSPORT |
133 |
481 |
2.175e-10 |
4.419e-09 |
230 |
TELENCEPHALON DEVELOPMENT |
76 |
228 |
2.306e-10 |
4.664e-09 |
231 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
54 |
140 |
2.336e-10 |
4.706e-09 |
232 |
LEUKOCYTE DIFFERENTIATION |
91 |
292 |
2.376e-10 |
4.765e-09 |
233 |
HEART MORPHOGENESIS |
72 |
212 |
2.643e-10 |
5.278e-09 |
234 |
GLAND DEVELOPMENT |
114 |
395 |
2.722e-10 |
5.413e-09 |
235 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
65 |
184 |
3.003e-10 |
5.946e-09 |
236 |
REGULATION OF SECRETION |
178 |
699 |
3.247e-10 |
6.402e-09 |
237 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
104 |
352 |
3.908e-10 |
7.672e-09 |
238 |
ACTION POTENTIAL |
41 |
94 |
4.295e-10 |
8.397e-09 |
239 |
HOMEOSTATIC PROCESS |
303 |
1337 |
4.689e-10 |
9.129e-09 |
240 |
EPITHELIAL CELL DEVELOPMENT |
65 |
186 |
5.04e-10 |
9.731e-09 |
241 |
PEPTIDYL TYROSINE MODIFICATION |
65 |
186 |
5.04e-10 |
9.731e-09 |
242 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
35 |
74 |
5.486e-10 |
1.055e-08 |
243 |
MEMBRANE DEPOLARIZATION |
31 |
61 |
5.53e-10 |
1.059e-08 |
244 |
REGULATION OF INTRACELLULAR TRANSPORT |
161 |
621 |
5.739e-10 |
1.094e-08 |
245 |
REGULATION OF ENDOCYTOSIS |
68 |
199 |
6.106e-10 |
1.16e-08 |
246 |
REGULATION OF JNK CASCADE |
58 |
159 |
6.557e-10 |
1.24e-08 |
247 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
127 |
462 |
8.307e-10 |
1.565e-08 |
248 |
REGULATION OF CHEMOTAXIS |
63 |
180 |
8.623e-10 |
1.618e-08 |
249 |
CARDIOCYTE DIFFERENTIATION |
41 |
96 |
9.359e-10 |
1.749e-08 |
250 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
42 |
100 |
1.093e-09 |
2.034e-08 |
251 |
LUNG ALVEOLUS DEVELOPMENT |
24 |
41 |
1.122e-09 |
2.081e-08 |
252 |
NEPHRON DEVELOPMENT |
46 |
115 |
1.231e-09 |
2.273e-08 |
253 |
MODULATION OF SYNAPTIC TRANSMISSION |
91 |
301 |
1.35e-09 |
2.482e-08 |
254 |
GLAND MORPHOGENESIS |
41 |
97 |
1.366e-09 |
2.492e-08 |
255 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
32 |
66 |
1.361e-09 |
2.492e-08 |
256 |
PLATELET ACTIVATION |
53 |
142 |
1.372e-09 |
2.494e-08 |
257 |
CALCIUM MEDIATED SIGNALING |
39 |
90 |
1.434e-09 |
2.585e-08 |
258 |
ENDOTHELIUM DEVELOPMENT |
39 |
90 |
1.434e-09 |
2.585e-08 |
259 |
NEGATIVE REGULATION OF GENE EXPRESSION |
330 |
1493 |
1.458e-09 |
2.62e-08 |
260 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
58 |
162 |
1.493e-09 |
2.673e-08 |
261 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
45 |
112 |
1.568e-09 |
2.795e-08 |
262 |
LEUKOCYTE MIGRATION |
81 |
259 |
1.892e-09 |
3.36e-08 |
263 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
23 |
39 |
2.039e-09 |
3.608e-08 |
264 |
POSITIVE REGULATION OF OSSIFICATION |
37 |
84 |
2.162e-09 |
3.811e-08 |
265 |
CARDIAC CHAMBER DEVELOPMENT |
53 |
144 |
2.446e-09 |
4.294e-08 |
266 |
CELL SUBSTRATE ADHESION |
58 |
164 |
2.541e-09 |
4.429e-08 |
267 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
31 |
64 |
2.532e-09 |
4.429e-08 |
268 |
SKELETAL SYSTEM MORPHOGENESIS |
67 |
201 |
2.629e-09 |
4.564e-08 |
269 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
42 |
103 |
3.21e-09 |
5.552e-08 |
270 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
127 |
472 |
3.508e-09 |
6.045e-08 |
271 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
22 |
37 |
3.697e-09 |
6.347e-08 |
272 |
GLOMERULUS DEVELOPMENT |
26 |
49 |
4.104e-09 |
6.994e-08 |
273 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
26 |
49 |
4.104e-09 |
6.994e-08 |
274 |
CARDIAC MUSCLE CELL CONTRACTION |
19 |
29 |
4.289e-09 |
7.283e-08 |
275 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
55 |
154 |
4.346e-09 |
7.326e-08 |
276 |
AMEBOIDAL TYPE CELL MIGRATION |
55 |
154 |
4.346e-09 |
7.326e-08 |
277 |
CELL PROLIFERATION |
168 |
672 |
4.367e-09 |
7.335e-08 |
278 |
RESPONSE TO PEPTIDE |
112 |
404 |
4.911e-09 |
8.19e-08 |
279 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
112 |
404 |
4.911e-09 |
8.19e-08 |
280 |
PATTERN SPECIFICATION PROCESS |
115 |
418 |
4.934e-09 |
8.199e-08 |
281 |
REGULATION OF ERK1 AND ERK2 CASCADE |
75 |
238 |
5.137e-09 |
8.506e-08 |
282 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
49 |
131 |
5.208e-09 |
8.563e-08 |
283 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
49 |
131 |
5.208e-09 |
8.563e-08 |
284 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
50 |
135 |
5.37e-09 |
8.798e-08 |
285 |
SYNAPSE ASSEMBLY |
32 |
69 |
5.504e-09 |
8.985e-08 |
286 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
170 |
684 |
5.557e-09 |
9.041e-08 |
287 |
REGULATION OF CELL MATRIX ADHESION |
38 |
90 |
5.612e-09 |
9.099e-08 |
288 |
RESPONSE TO ACID CHEMICAL |
93 |
319 |
6.822e-09 |
1.095e-07 |
289 |
REGULATION OF WNT SIGNALING PATHWAY |
91 |
310 |
6.828e-09 |
1.095e-07 |
290 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
249 |
1087 |
6.794e-09 |
1.095e-07 |
291 |
REGULATION OF STEM CELL DIFFERENTIATION |
44 |
113 |
7.476e-09 |
1.195e-07 |
292 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
45 |
117 |
7.958e-09 |
1.268e-07 |
293 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
80 |
262 |
8.009e-09 |
1.272e-07 |
294 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
32 |
70 |
8.549e-09 |
1.353e-07 |
295 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
86 |
289 |
8.71e-09 |
1.374e-07 |
296 |
KIDNEY EPITHELIUM DEVELOPMENT |
47 |
125 |
8.751e-09 |
1.376e-07 |
297 |
FAT CELL DIFFERENTIATION |
42 |
106 |
8.886e-09 |
1.392e-07 |
298 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
49 |
133 |
9.3e-09 |
1.452e-07 |
299 |
RESPONSE TO ALCOHOL |
102 |
362 |
9.446e-09 |
1.47e-07 |
300 |
NEURON MIGRATION |
43 |
110 |
9.603e-09 |
1.489e-07 |
301 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
54 |
153 |
9.64e-09 |
1.49e-07 |
302 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
70 |
220 |
1.057e-08 |
1.629e-07 |
303 |
PLASMA MEMBRANE ORGANIZATION |
66 |
203 |
1.064e-08 |
1.632e-07 |
304 |
NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS |
104 |
372 |
1.066e-08 |
1.632e-07 |
305 |
REGULATION OF IMMUNE SYSTEM PROCESS |
308 |
1403 |
1.13e-08 |
1.723e-07 |
306 |
REGULATION OF ORGAN MORPHOGENESIS |
75 |
242 |
1.148e-08 |
1.746e-07 |
307 |
EAR DEVELOPMENT |
64 |
195 |
1.172e-08 |
1.777e-07 |
308 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
63 |
191 |
1.226e-08 |
1.852e-07 |
309 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
66 |
204 |
1.324e-08 |
1.994e-07 |
310 |
REGULATION OF PROTEIN IMPORT |
61 |
183 |
1.332e-08 |
1.999e-07 |
311 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
22 |
39 |
1.438e-08 |
2.151e-07 |
312 |
LEARNING |
48 |
131 |
1.607e-08 |
2.397e-07 |
313 |
ACTIN FILAMENT BASED MOVEMENT |
38 |
93 |
1.662e-08 |
2.47e-07 |
314 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
111 |
408 |
1.767e-08 |
2.618e-07 |
315 |
RESPONSE TO CORTICOSTEROID |
59 |
176 |
1.812e-08 |
2.676e-07 |
316 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
27 |
55 |
1.864e-08 |
2.745e-07 |
317 |
REGULATION OF AXONOGENESIS |
57 |
168 |
1.934e-08 |
2.839e-07 |
318 |
REGULATION OF DENDRITE DEVELOPMENT |
45 |
120 |
1.978e-08 |
2.894e-07 |
319 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
53 |
152 |
2.114e-08 |
3.083e-07 |
320 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
76 |
250 |
2.312e-08 |
3.351e-07 |
321 |
REGULATION OF LIPASE ACTIVITY |
35 |
83 |
2.31e-08 |
3.351e-07 |
322 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
110 |
406 |
2.602e-08 |
3.76e-07 |
323 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
21 |
37 |
2.65e-08 |
3.817e-07 |
324 |
OSSIFICATION |
76 |
251 |
2.79e-08 |
4.007e-07 |
325 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
327 |
1517 |
2.835e-08 |
4.059e-07 |
326 |
WNT SIGNALING PATHWAY |
98 |
351 |
3.015e-08 |
4.304e-07 |
327 |
REGULATION OF PROTEIN SECRETION |
106 |
389 |
3.366e-08 |
4.789e-07 |
328 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
26 |
53 |
3.477e-08 |
4.932e-07 |
329 |
PROTEIN AUTOPHOSPHORYLATION |
62 |
192 |
3.896e-08 |
5.511e-07 |
330 |
POSITIVE REGULATION OF CELL ADHESION |
103 |
376 |
3.921e-08 |
5.529e-07 |
331 |
LEUKOCYTE ACTIVATION |
111 |
414 |
4.128e-08 |
5.802e-07 |
332 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
28 |
60 |
4.147e-08 |
5.812e-07 |
333 |
CELL FATE COMMITMENT |
70 |
227 |
4.355e-08 |
6.085e-07 |
334 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
72 |
236 |
4.565e-08 |
6.34e-07 |
335 |
NEGATIVE REGULATION OF GROWTH |
72 |
236 |
4.565e-08 |
6.34e-07 |
336 |
HEART PROCESS |
35 |
85 |
4.785e-08 |
6.627e-07 |
337 |
COLLAGEN FIBRIL ORGANIZATION |
21 |
38 |
5.006e-08 |
6.912e-07 |
338 |
CELL JUNCTION ORGANIZATION |
60 |
185 |
5.379e-08 |
7.405e-07 |
339 |
DIGESTIVE SYSTEM DEVELOPMENT |
51 |
148 |
5.998e-08 |
8.209e-07 |
340 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
43 |
116 |
5.985e-08 |
8.209e-07 |
341 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
65 |
207 |
6.12e-08 |
8.35e-07 |
342 |
MUSCLE CELL DEVELOPMENT |
46 |
128 |
6.271e-08 |
8.507e-07 |
343 |
EYE MORPHOGENESIS |
48 |
136 |
6.258e-08 |
8.507e-07 |
344 |
APPENDAGE DEVELOPMENT |
56 |
169 |
6.487e-08 |
8.749e-07 |
345 |
LIMB DEVELOPMENT |
56 |
169 |
6.487e-08 |
8.749e-07 |
346 |
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION |
17 |
27 |
6.854e-08 |
9.217e-07 |
347 |
CELLULAR RESPONSE TO PEPTIDE |
80 |
274 |
7.042e-08 |
9.443e-07 |
348 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
242 |
1079 |
7.504e-08 |
1.003e-06 |
349 |
REGULATION OF STRIATED MUSCLE CONTRACTION |
33 |
79 |
7.596e-08 |
1.013e-06 |
350 |
REGULATION OF SYNAPSE ORGANIZATION |
42 |
113 |
7.778e-08 |
1.034e-06 |
351 |
SECRETION BY CELL |
125 |
486 |
7.864e-08 |
1.042e-06 |
352 |
ENDOTHELIAL CELL DIFFERENTIATION |
31 |
72 |
8.124e-08 |
1.071e-06 |
353 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
44 |
121 |
8.108e-08 |
1.071e-06 |
354 |
REGULATION OF CELL GROWTH |
105 |
391 |
8.728e-08 |
1.147e-06 |
355 |
RESPONSE TO MOLECULE OF BACTERIAL ORIGIN |
90 |
321 |
8.842e-08 |
1.159e-06 |
356 |
ION TRANSPORT |
276 |
1262 |
9.899e-08 |
1.294e-06 |
357 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
42 |
114 |
1.038e-07 |
1.353e-06 |
358 |
RESPONSE TO INORGANIC SUBSTANCE |
123 |
479 |
1.098e-07 |
1.427e-06 |
359 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
148 |
602 |
1.118e-07 |
1.449e-06 |
360 |
MEMBRANE ASSEMBLY |
16 |
25 |
1.208e-07 |
1.561e-06 |
361 |
SECRETION |
145 |
588 |
1.234e-07 |
1.589e-06 |
362 |
POSITIVE REGULATION OF LIPASE ACTIVITY |
29 |
66 |
1.236e-07 |
1.589e-06 |
363 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
23 |
46 |
1.367e-07 |
1.752e-06 |
364 |
REGULATION OF SODIUM ION TRANSPORT |
32 |
77 |
1.375e-07 |
1.756e-06 |
365 |
RESPONSE TO CALCIUM ION |
42 |
115 |
1.378e-07 |
1.756e-06 |
366 |
SYSTEM PROCESS |
372 |
1785 |
1.412e-07 |
1.795e-06 |
367 |
LOCOMOTORY BEHAVIOR |
58 |
181 |
1.421e-07 |
1.802e-06 |
368 |
REGULATION OF MUSCLE ADAPTATION |
28 |
63 |
1.513e-07 |
1.91e-06 |
369 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
79 |
274 |
1.514e-07 |
1.91e-06 |
370 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
52 |
156 |
1.522e-07 |
1.914e-06 |
371 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
165 |
691 |
1.656e-07 |
2.076e-06 |
372 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
39 |
104 |
1.703e-07 |
2.13e-06 |
373 |
FEMALE SEX DIFFERENTIATION |
42 |
116 |
1.82e-07 |
2.27e-06 |
374 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
29 |
67 |
1.84e-07 |
2.277e-06 |
375 |
CHONDROCYTE DIFFERENTIATION |
27 |
60 |
1.839e-07 |
2.277e-06 |
376 |
INOSITOL LIPID MEDIATED SIGNALING |
44 |
124 |
1.831e-07 |
2.277e-06 |
377 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
65 |
213 |
1.996e-07 |
2.464e-06 |
378 |
REGULATION OF INFLAMMATORY RESPONSE |
83 |
294 |
2.008e-07 |
2.471e-06 |
379 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
37 |
97 |
2.115e-07 |
2.596e-06 |
380 |
CAMERA TYPE EYE MORPHOGENESIS |
38 |
101 |
2.209e-07 |
2.705e-06 |
381 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
66 |
218 |
2.236e-07 |
2.73e-06 |
382 |
ODONTOGENESIS |
39 |
105 |
2.283e-07 |
2.781e-06 |
383 |
CELL CHEMOTAXIS |
53 |
162 |
2.297e-07 |
2.79e-06 |
384 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
40 |
109 |
2.338e-07 |
2.833e-06 |
385 |
ARTERY DEVELOPMENT |
31 |
75 |
2.487e-07 |
3.006e-06 |
386 |
REGULATION OF CELL JUNCTION ASSEMBLY |
29 |
68 |
2.707e-07 |
3.255e-06 |
387 |
ORGAN GROWTH |
29 |
68 |
2.707e-07 |
3.255e-06 |
388 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
60 |
193 |
2.856e-07 |
3.425e-06 |
389 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
37 |
98 |
2.864e-07 |
3.426e-06 |
390 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
38 |
102 |
2.968e-07 |
3.541e-06 |
391 |
REGULATED EXOCYTOSIS |
67 |
224 |
2.99e-07 |
3.558e-06 |
392 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
20 |
38 |
3.051e-07 |
3.621e-06 |
393 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
55 |
172 |
3.192e-07 |
3.764e-06 |
394 |
REGULATION OF ACTIN FILAMENT BASED MOVEMENT |
18 |
32 |
3.189e-07 |
3.764e-06 |
395 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
136 |
552 |
3.195e-07 |
3.764e-06 |
396 |
ENSHEATHMENT OF NEURONS |
35 |
91 |
3.531e-07 |
4.139e-06 |
397 |
AXON ENSHEATHMENT |
35 |
91 |
3.531e-07 |
4.139e-06 |
398 |
POSITIVE REGULATION OF TRANSPORTER ACTIVITY |
31 |
76 |
3.544e-07 |
4.144e-06 |
399 |
REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT |
23 |
48 |
3.669e-07 |
4.279e-06 |
400 |
CELL GROWTH |
46 |
135 |
3.794e-07 |
4.414e-06 |
401 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
37 |
99 |
3.856e-07 |
4.463e-06 |
402 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
37 |
99 |
3.856e-07 |
4.463e-06 |
403 |
CELL MATRIX ADHESION |
42 |
119 |
4.077e-07 |
4.707e-06 |
404 |
REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
50 |
152 |
4.136e-07 |
4.764e-06 |
405 |
FOREBRAIN CELL MIGRATION |
27 |
62 |
4.166e-07 |
4.786e-06 |
406 |
SPROUTING ANGIOGENESIS |
22 |
45 |
4.227e-07 |
4.845e-06 |
407 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
48 |
144 |
4.501e-07 |
5.146e-06 |
408 |
MULTI MULTICELLULAR ORGANISM PROCESS |
64 |
213 |
4.564e-07 |
5.205e-06 |
409 |
REGULATION OF HEART GROWTH |
21 |
42 |
4.784e-07 |
5.442e-06 |
410 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
35 |
92 |
4.807e-07 |
5.455e-06 |
411 |
ION HOMEOSTASIS |
140 |
576 |
4.947e-07 |
5.601e-06 |
412 |
DEVELOPMENTAL CELL GROWTH |
31 |
77 |
5.006e-07 |
5.654e-06 |
413 |
PALLIUM DEVELOPMENT |
50 |
153 |
5.175e-07 |
5.831e-06 |
414 |
CARDIAC CHAMBER MORPHOGENESIS |
38 |
104 |
5.267e-07 |
5.92e-06 |
415 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
20 |
39 |
5.297e-07 |
5.939e-06 |
416 |
EAR MORPHOGENESIS |
40 |
112 |
5.351e-07 |
5.986e-06 |
417 |
POSITIVE REGULATION OF HEART GROWTH |
16 |
27 |
5.532e-07 |
6.173e-06 |
418 |
MEMBRANE BIOGENESIS |
17 |
30 |
5.908e-07 |
6.529e-06 |
419 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
17 |
30 |
5.908e-07 |
6.529e-06 |
420 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
17 |
30 |
5.908e-07 |
6.529e-06 |
421 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
17 |
30 |
5.908e-07 |
6.529e-06 |
422 |
REGULATION OF CARTILAGE DEVELOPMENT |
27 |
63 |
6.155e-07 |
6.787e-06 |
423 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
25 |
56 |
6.267e-07 |
6.894e-06 |
424 |
REGULATION OF DENDRITE MORPHOGENESIS |
30 |
74 |
6.377e-07 |
6.998e-06 |
425 |
CELL JUNCTION ASSEMBLY |
44 |
129 |
6.525e-07 |
7.144e-06 |
426 |
REGULATION OF RECEPTOR ACTIVITY |
41 |
117 |
6.923e-07 |
7.562e-06 |
427 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
28 |
67 |
7.158e-07 |
7.8e-06 |
428 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
26 |
60 |
7.64e-07 |
8.306e-06 |
429 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
64 |
216 |
7.861e-07 |
8.526e-06 |
430 |
SEX DIFFERENTIATION |
75 |
266 |
8.029e-07 |
8.688e-06 |
431 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
49 |
151 |
8.463e-07 |
9.118e-06 |
432 |
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION |
14 |
22 |
8.466e-07 |
9.118e-06 |
433 |
POSITIVE REGULATION OF SECRETION |
97 |
370 |
8.763e-07 |
9.416e-06 |
434 |
PROTEIN LOCALIZATION |
370 |
1805 |
8.874e-07 |
9.514e-06 |
435 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
23 |
50 |
9.147e-07 |
9.785e-06 |
436 |
CELL DEATH |
221 |
1001 |
9.654e-07 |
1.03e-05 |
437 |
BONE MORPHOGENESIS |
31 |
79 |
9.736e-07 |
1.037e-05 |
438 |
REGULATION OF BLOOD PRESSURE |
53 |
169 |
1.02e-06 |
1.083e-05 |
439 |
NEGATIVE REGULATION OF ION TRANSPORT |
43 |
127 |
1.09e-06 |
1.156e-05 |
440 |
MUSCLE HYPERTROPHY |
16 |
28 |
1.094e-06 |
1.157e-05 |
441 |
LYMPHOCYTE DIFFERENTIATION |
62 |
209 |
1.11e-06 |
1.171e-05 |
442 |
AGING |
74 |
264 |
1.208e-06 |
1.272e-05 |
443 |
NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT |
31 |
80 |
1.341e-06 |
1.409e-05 |
444 |
NEURAL CREST CELL MIGRATION |
23 |
51 |
1.408e-06 |
1.476e-05 |
445 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
32 |
84 |
1.417e-06 |
1.481e-05 |
446 |
GLIOGENESIS |
54 |
175 |
1.42e-06 |
1.481e-05 |
447 |
NEGATIVE REGULATION OF MAPK CASCADE |
47 |
145 |
1.455e-06 |
1.515e-05 |
448 |
OVULATION CYCLE PROCESS |
33 |
88 |
1.476e-06 |
1.533e-05 |
449 |
RESPONSE TO PURINE CONTAINING COMPOUND |
50 |
158 |
1.516e-06 |
1.571e-05 |
450 |
INNER EAR MORPHOGENESIS |
34 |
92 |
1.52e-06 |
1.571e-05 |
451 |
REGULATION OF CYTOSKELETON ORGANIZATION |
123 |
502 |
1.563e-06 |
1.613e-05 |
452 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
11 |
15 |
1.619e-06 |
1.667e-05 |
453 |
REGULATION OF ACTION POTENTIAL |
19 |
38 |
1.68e-06 |
1.726e-05 |
454 |
REGULATION OF KIDNEY DEVELOPMENT |
24 |
55 |
1.734e-06 |
1.778e-05 |
455 |
REGULATION OF CELLULAR COMPONENT SIZE |
89 |
337 |
1.752e-06 |
1.792e-05 |
456 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
47 |
146 |
1.808e-06 |
1.841e-05 |
457 |
LYMPHOCYTE ACTIVATION |
90 |
342 |
1.806e-06 |
1.841e-05 |
458 |
METANEPHROS DEVELOPMENT |
31 |
81 |
1.834e-06 |
1.857e-05 |
459 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING |
14 |
23 |
1.836e-06 |
1.857e-05 |
460 |
REGULATION OF METANEPHROS DEVELOPMENT |
14 |
23 |
1.836e-06 |
1.857e-05 |
461 |
REGULATION OF CARDIAC CONDUCTION |
27 |
66 |
1.856e-06 |
1.873e-05 |
462 |
OVULATION CYCLE |
39 |
113 |
1.978e-06 |
1.992e-05 |
463 |
NEPHRON EPITHELIUM DEVELOPMENT |
34 |
93 |
2.021e-06 |
2.031e-05 |
464 |
CEREBRAL CORTEX DEVELOPMENT |
37 |
105 |
2.038e-06 |
2.044e-05 |
465 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
80 |
296 |
2.202e-06 |
2.203e-05 |
466 |
ACTIN MEDIATED CELL CONTRACTION |
29 |
74 |
2.227e-06 |
2.22e-05 |
467 |
DIVALENT INORGANIC CATION TRANSPORT |
74 |
268 |
2.228e-06 |
2.22e-05 |
468 |
RESPONSE TO KETONE |
55 |
182 |
2.341e-06 |
2.327e-05 |
469 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
46 |
143 |
2.371e-06 |
2.352e-05 |
470 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
63 |
218 |
2.423e-06 |
2.399e-05 |
471 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
61 |
209 |
2.438e-06 |
2.409e-05 |
472 |
VESICLE MEDIATED TRANSPORT |
263 |
1239 |
2.572e-06 |
2.536e-05 |
473 |
CALCIUM ION TRANSPORT |
64 |
223 |
2.616e-06 |
2.573e-05 |
474 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
37 |
106 |
2.641e-06 |
2.576e-05 |
475 |
REGULATION OF FAT CELL DIFFERENTIATION |
37 |
106 |
2.641e-06 |
2.576e-05 |
476 |
CARDIAC VENTRICLE DEVELOPMENT |
37 |
106 |
2.641e-06 |
2.576e-05 |
477 |
CELLULAR MACROMOLECULE LOCALIZATION |
262 |
1234 |
2.639e-06 |
2.576e-05 |
478 |
RESPONSE TO INSULIN |
60 |
205 |
2.659e-06 |
2.589e-05 |
479 |
RENAL SYSTEM PROCESS |
36 |
102 |
2.671e-06 |
2.594e-05 |
480 |
MEMORY |
35 |
98 |
2.681e-06 |
2.599e-05 |
481 |
NEGATIVE CHEMOTAXIS |
19 |
39 |
2.774e-06 |
2.683e-05 |
482 |
NEGATIVE REGULATION OF CELL GROWTH |
52 |
170 |
2.94e-06 |
2.838e-05 |
483 |
REGULATION OF SMOOTH MUSCLE CONTRACTION |
25 |
60 |
2.974e-06 |
2.865e-05 |
484 |
REGULATION OF SYNAPTIC PLASTICITY |
45 |
140 |
3.108e-06 |
2.988e-05 |
485 |
DENDRITE DEVELOPMENT |
30 |
79 |
3.229e-06 |
3.098e-05 |
486 |
REGULATION OF POTASSIUM ION TRANSPORT |
31 |
83 |
3.353e-06 |
3.21e-05 |
487 |
LIPID PHOSPHORYLATION |
35 |
99 |
3.499e-06 |
3.343e-05 |
488 |
RESPONSE TO OXIDATIVE STRESS |
91 |
352 |
3.532e-06 |
3.367e-05 |
489 |
REGULATION OF HORMONE SECRETION |
72 |
262 |
3.654e-06 |
3.476e-05 |
490 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
27 |
68 |
3.678e-06 |
3.493e-05 |
491 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
24 |
57 |
3.745e-06 |
3.534e-05 |
492 |
ENDOTHELIAL CELL MIGRATION |
24 |
57 |
3.745e-06 |
3.534e-05 |
493 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
14 |
24 |
3.739e-06 |
3.534e-05 |
494 |
REGULATION OF MEMBRANE REPOLARIZATION |
16 |
30 |
3.756e-06 |
3.538e-05 |
495 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
89 |
343 |
3.832e-06 |
3.602e-05 |
496 |
RESPONSE TO DRUG |
107 |
431 |
3.903e-06 |
3.661e-05 |
497 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
25 |
61 |
4.258e-06 |
3.987e-05 |
498 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
11 |
16 |
4.409e-06 |
4.12e-05 |
499 |
REGULATION OF NEUROTRANSMITTER LEVELS |
56 |
190 |
4.462e-06 |
4.16e-05 |
500 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
35 |
100 |
4.541e-06 |
4.226e-05 |
501 |
REGULATION OF STEM CELL PROLIFERATION |
32 |
88 |
4.561e-06 |
4.236e-05 |
502 |
REPRODUCTION |
272 |
1297 |
4.671e-06 |
4.33e-05 |
503 |
IN UTERO EMBRYONIC DEVELOPMENT |
82 |
311 |
4.701e-06 |
4.349e-05 |
504 |
POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
21 |
47 |
4.829e-06 |
4.458e-05 |
505 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
40 |
121 |
4.986e-06 |
4.594e-05 |
506 |
REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
18 |
37 |
5.202e-06 |
4.784e-05 |
507 |
NEGATIVE REGULATION OF SECRETION |
58 |
200 |
5.302e-06 |
4.866e-05 |
508 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
93 |
365 |
5.312e-06 |
4.866e-05 |
509 |
REGULATION OF ORGAN GROWTH |
28 |
73 |
5.423e-06 |
4.958e-05 |
510 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
17 |
34 |
5.929e-06 |
5.388e-05 |
511 |
POSITIVE REGULATION OF SODIUM ION TRANSPORT |
17 |
34 |
5.929e-06 |
5.388e-05 |
512 |
CAMP METABOLIC PROCESS |
17 |
34 |
5.929e-06 |
5.388e-05 |
513 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
41 |
126 |
5.955e-06 |
5.401e-05 |
514 |
APOPTOTIC SIGNALING PATHWAY |
77 |
289 |
5.994e-06 |
5.426e-05 |
515 |
RESPONSE TO ORGANOPHOSPHORUS |
44 |
139 |
6.221e-06 |
5.61e-05 |
516 |
ACTIN FILAMENT ORGANIZATION |
52 |
174 |
6.22e-06 |
5.61e-05 |
517 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
40 |
122 |
6.255e-06 |
5.619e-05 |
518 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
40 |
122 |
6.255e-06 |
5.619e-05 |
519 |
REGULATION OF CATABOLIC PROCESS |
165 |
731 |
6.29e-06 |
5.639e-05 |
520 |
REGENERATION |
49 |
161 |
6.537e-06 |
5.849e-05 |
521 |
ADULT BEHAVIOR |
43 |
135 |
6.613e-06 |
5.906e-05 |
522 |
METAL ION TRANSPORT |
136 |
582 |
6.632e-06 |
5.911e-05 |
523 |
REGULATION OF EMBRYONIC DEVELOPMENT |
38 |
114 |
6.828e-06 |
6.075e-05 |
524 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
57 |
197 |
6.865e-06 |
6.096e-05 |
525 |
REGULATION OF HEMOPOIESIS |
82 |
314 |
6.973e-06 |
6.18e-05 |
526 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
27 |
70 |
7.019e-06 |
6.209e-05 |
527 |
REGULATION OF MEMBRANE DEPOLARIZATION |
19 |
41 |
7.056e-06 |
6.23e-05 |
528 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM |
14 |
25 |
7.213e-06 |
6.356e-05 |
529 |
DIGESTIVE TRACT MORPHOGENESIS |
21 |
48 |
7.262e-06 |
6.388e-05 |
530 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
49 |
162 |
7.897e-06 |
6.907e-05 |
531 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
49 |
162 |
7.897e-06 |
6.907e-05 |
532 |
MESONEPHROS DEVELOPMENT |
32 |
90 |
7.873e-06 |
6.907e-05 |
533 |
REGULATION OF LEUKOCYTE MIGRATION |
46 |
149 |
8.154e-06 |
7.119e-05 |
534 |
REGULATION OF HORMONE LEVELS |
115 |
478 |
8.382e-06 |
7.249e-05 |
535 |
POSITIVE REGULATION OF POTASSIUM ION TRANSPORT |
18 |
38 |
8.372e-06 |
7.249e-05 |
536 |
REGULATION OF RENAL SYSTEM PROCESS |
18 |
38 |
8.372e-06 |
7.249e-05 |
537 |
POSITIVE REGULATION OF ORGAN GROWTH |
18 |
38 |
8.372e-06 |
7.249e-05 |
538 |
REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
18 |
38 |
8.372e-06 |
7.249e-05 |
539 |
REGULATION OF LIPID METABOLIC PROCESS |
75 |
282 |
8.429e-06 |
7.277e-05 |
540 |
REGIONALIZATION |
81 |
311 |
8.803e-06 |
7.585e-05 |
541 |
ENDOTHELIAL CELL DEVELOPMENT |
20 |
45 |
8.94e-06 |
7.675e-05 |
542 |
SMOOTH MUSCLE CONTRACTION |
20 |
45 |
8.94e-06 |
7.675e-05 |
543 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
36 |
107 |
9.314e-06 |
7.952e-05 |
544 |
SYNAPTIC SIGNALING |
104 |
424 |
9.288e-06 |
7.952e-05 |
545 |
PLATELET DEGRANULATION |
36 |
107 |
9.314e-06 |
7.952e-05 |
546 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
35 |
103 |
9.625e-06 |
8.202e-05 |
547 |
REGULATION OF BINDING |
75 |
283 |
9.655e-06 |
8.213e-05 |
548 |
REGULATION OF CELL SIZE |
51 |
172 |
9.697e-06 |
8.234e-05 |
549 |
RESPONSE TO MONOAMINE |
17 |
35 |
9.769e-06 |
8.265e-05 |
550 |
REGULATION OF PROTEIN TARGETING |
80 |
307 |
9.766e-06 |
8.265e-05 |
551 |
OUTFLOW TRACT MORPHOGENESIS |
23 |
56 |
9.791e-06 |
8.268e-05 |
552 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
34 |
99 |
9.891e-06 |
8.338e-05 |
553 |
REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
28 |
75 |
9.932e-06 |
8.341e-05 |
554 |
NEURAL CREST CELL DIFFERENTIATION |
28 |
75 |
9.932e-06 |
8.341e-05 |
555 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
33 |
95 |
1.01e-05 |
8.471e-05 |
556 |
REGULATION OF SYNAPSE ASSEMBLY |
29 |
79 |
1.017e-05 |
8.512e-05 |
557 |
POSITIVE REGULATION OF CHEMOTAXIS |
39 |
120 |
1.026e-05 |
8.574e-05 |
558 |
CELLULAR RESPONSE TO CALCIUM ION |
21 |
49 |
1.075e-05 |
8.951e-05 |
559 |
CARDIAC CELL DEVELOPMENT |
21 |
49 |
1.075e-05 |
8.951e-05 |
560 |
CATION TRANSPORT |
176 |
796 |
1.134e-05 |
9.421e-05 |
561 |
MECHANOSENSORY BEHAVIOR |
9 |
12 |
1.158e-05 |
9.605e-05 |
562 |
RESPONSE TO METAL ION |
85 |
333 |
1.229e-05 |
0.0001018 |
563 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
15 |
29 |
1.24e-05 |
0.0001023 |
564 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
15 |
29 |
1.24e-05 |
0.0001023 |
565 |
CELLULAR RESPONSE TO AMINO ACID STIMULUS |
22 |
53 |
1.242e-05 |
0.0001023 |
566 |
REGULATION OF AMINE TRANSPORT |
27 |
72 |
1.293e-05 |
0.0001063 |
567 |
REGULATION OF NEURON DEATH |
68 |
252 |
1.3e-05 |
0.0001067 |
568 |
MESODERMAL CELL DIFFERENTIATION |
14 |
26 |
1.327e-05 |
0.0001087 |
569 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
189 |
867 |
1.345e-05 |
0.0001098 |
570 |
CELLULAR RESPONSE TO INORGANIC SUBSTANCE |
47 |
156 |
1.343e-05 |
0.0001098 |
571 |
TISSUE MIGRATION |
30 |
84 |
1.352e-05 |
0.0001102 |
572 |
RAS PROTEIN SIGNAL TRANSDUCTION |
44 |
143 |
1.394e-05 |
0.0001134 |
573 |
REGULATION OF CELL ACTIVATION |
115 |
484 |
1.528e-05 |
0.0001241 |
574 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
21 |
50 |
1.569e-05 |
0.0001267 |
575 |
CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
17 |
36 |
1.569e-05 |
0.0001267 |
576 |
CELLULAR RESPONSE TO CAMP |
21 |
50 |
1.569e-05 |
0.0001267 |
577 |
REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
25 |
65 |
1.61e-05 |
0.0001298 |
578 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
53 |
184 |
1.628e-05 |
0.0001311 |
579 |
NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION |
19 |
43 |
1.655e-05 |
0.000133 |
580 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
38 |
118 |
1.677e-05 |
0.0001345 |
581 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
32 |
93 |
1.708e-05 |
0.0001365 |
582 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
32 |
93 |
1.708e-05 |
0.0001365 |
583 |
MYELOID CELL DIFFERENTIATION |
54 |
189 |
1.754e-05 |
0.00014 |
584 |
CARDIAC SEPTUM DEVELOPMENT |
30 |
85 |
1.765e-05 |
0.0001404 |
585 |
PALATE DEVELOPMENT |
30 |
85 |
1.765e-05 |
0.0001404 |
586 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
57 |
203 |
1.825e-05 |
0.0001449 |
587 |
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT |
16 |
33 |
1.837e-05 |
0.0001454 |
588 |
EMBRYONIC EYE MORPHOGENESIS |
16 |
33 |
1.837e-05 |
0.0001454 |
589 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
70 |
264 |
1.846e-05 |
0.0001459 |
590 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
36 |
110 |
1.863e-05 |
0.0001469 |
591 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
94 |
381 |
1.915e-05 |
0.0001508 |
592 |
T CELL DIFFERENTIATION |
39 |
123 |
1.956e-05 |
0.0001537 |
593 |
GLIAL CELL DIFFERENTIATION |
42 |
136 |
1.96e-05 |
0.0001538 |
594 |
RESPONSE TO CYTOKINE |
159 |
714 |
2.001e-05 |
0.0001567 |
595 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
24 |
62 |
2.085e-05 |
0.000163 |
596 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
15 |
30 |
2.104e-05 |
0.0001643 |
597 |
VASCULAR PROCESS IN CIRCULATORY SYSTEM |
48 |
163 |
2.131e-05 |
0.0001661 |
598 |
RESPONSE TO ESTROGEN |
60 |
218 |
2.16e-05 |
0.0001681 |
599 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
25 |
66 |
2.19e-05 |
0.0001696 |
600 |
REGULATION OF VASOCONSTRICTION |
25 |
66 |
2.19e-05 |
0.0001696 |
601 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
25 |
66 |
2.19e-05 |
0.0001696 |
602 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
37 |
115 |
2.202e-05 |
0.0001702 |
603 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
31 |
90 |
2.244e-05 |
0.0001732 |
604 |
ARTERY MORPHOGENESIS |
21 |
51 |
2.257e-05 |
0.0001735 |
605 |
NEGATIVE REGULATION OF CHEMOTAXIS |
21 |
51 |
2.257e-05 |
0.0001735 |
606 |
REGULATION OF PEPTIDE SECRETION |
58 |
209 |
2.259e-05 |
0.0001735 |
607 |
REGULATION OF PEPTIDE TRANSPORT |
68 |
256 |
2.267e-05 |
0.0001737 |
608 |
NEGATIVE REGULATION OF CELL ADHESION |
61 |
223 |
2.269e-05 |
0.0001737 |
609 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS |
30 |
86 |
2.289e-05 |
0.0001749 |
610 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
11 |
18 |
2.327e-05 |
0.0001775 |
611 |
HIPPO SIGNALING |
14 |
27 |
2.34e-05 |
0.0001782 |
612 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
120 |
514 |
2.368e-05 |
0.00018 |
613 |
CIRCADIAN RHYTHM |
42 |
137 |
2.383e-05 |
0.0001806 |
614 |
SKELETAL MUSCLE ORGAN DEVELOPMENT |
42 |
137 |
2.383e-05 |
0.0001806 |
615 |
ENDOCYTOSIS |
119 |
509 |
2.391e-05 |
0.0001809 |
616 |
REGULATION OF MUSCLE HYPERTROPHY |
17 |
37 |
2.46e-05 |
0.0001858 |
617 |
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS |
13 |
24 |
2.499e-05 |
0.0001884 |
618 |
REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION |
12 |
21 |
2.519e-05 |
0.0001896 |
619 |
REGULATION OF CALCIUM ION IMPORT |
34 |
103 |
2.566e-05 |
0.0001926 |
620 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
34 |
103 |
2.566e-05 |
0.0001926 |
621 |
POSITIVE REGULATION OF GROWTH |
64 |
238 |
2.585e-05 |
0.0001937 |
622 |
LIPID MODIFICATION |
58 |
210 |
2.629e-05 |
0.0001967 |
623 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
23 |
59 |
2.697e-05 |
0.0002014 |
624 |
TUBE FORMATION |
40 |
129 |
2.754e-05 |
0.0002053 |
625 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
20 |
48 |
2.863e-05 |
0.0002132 |
626 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
52 |
183 |
2.926e-05 |
0.0002175 |
627 |
RESPONSE TO FLUID SHEAR STRESS |
16 |
34 |
2.943e-05 |
0.000218 |
628 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
16 |
34 |
2.943e-05 |
0.000218 |
629 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
73 |
282 |
2.971e-05 |
0.0002198 |
630 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
46 |
156 |
3.016e-05 |
0.0002228 |
631 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
28 |
79 |
3.041e-05 |
0.0002239 |
632 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
27 |
75 |
3.047e-05 |
0.0002239 |
633 |
MULTI ORGANISM BEHAVIOR |
27 |
75 |
3.047e-05 |
0.0002239 |
634 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
18 |
41 |
3.064e-05 |
0.0002249 |
635 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
76 |
297 |
3.157e-05 |
0.0002314 |
636 |
REGULATION OF VASCULOGENESIS |
9 |
13 |
3.213e-05 |
0.0002339 |
637 |
VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION |
9 |
13 |
3.213e-05 |
0.0002339 |
638 |
EYELID DEVELOPMENT IN CAMERA TYPE EYE |
9 |
13 |
3.213e-05 |
0.0002339 |
639 |
ACTIVATION OF MAPKK ACTIVITY |
21 |
52 |
3.204e-05 |
0.0002339 |
640 |
POSITIVE REGULATION OF PROTEIN IMPORT |
34 |
104 |
3.218e-05 |
0.000234 |
641 |
DEVELOPMENTAL MATURATION |
54 |
193 |
3.327e-05 |
0.0002415 |
642 |
LIPID LOCALIZATION |
69 |
264 |
3.484e-05 |
0.0002525 |
643 |
REGULATION OF CELL SHAPE |
42 |
139 |
3.491e-05 |
0.0002526 |
644 |
HOMEOSTASIS OF NUMBER OF CELLS |
50 |
175 |
3.524e-05 |
0.0002546 |
645 |
CELLULAR CHEMICAL HOMEOSTASIS |
130 |
570 |
3.568e-05 |
0.0002574 |
646 |
REGULATION OF WOUND HEALING |
39 |
126 |
3.606e-05 |
0.0002597 |
647 |
REGULATION OF GLUCOSE IMPORT |
23 |
60 |
3.699e-05 |
0.0002648 |
648 |
STEM CELL PROLIFERATION |
23 |
60 |
3.699e-05 |
0.0002648 |
649 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
23 |
60 |
3.699e-05 |
0.0002648 |
650 |
OLIGODENDROCYTE DIFFERENTIATION |
23 |
60 |
3.699e-05 |
0.0002648 |
651 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
17 |
38 |
3.774e-05 |
0.0002697 |
652 |
REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
29 |
84 |
3.881e-05 |
0.0002769 |
653 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
20 |
49 |
4.097e-05 |
0.0002919 |
654 |
CELLULAR HOMEOSTASIS |
150 |
676 |
4.115e-05 |
0.0002928 |
655 |
REGULATION OF MONONUCLEAR CELL MIGRATION |
10 |
16 |
4.245e-05 |
0.0002993 |
656 |
REGULATION OF MACROPHAGE CHEMOTAXIS |
10 |
16 |
4.245e-05 |
0.0002993 |
657 |
NEURON CELL CELL ADHESION |
10 |
16 |
4.245e-05 |
0.0002993 |
658 |
RESPONSE TO EPINEPHRINE |
10 |
16 |
4.245e-05 |
0.0002993 |
659 |
STRIATUM DEVELOPMENT |
10 |
16 |
4.245e-05 |
0.0002993 |
660 |
REGULATION OF EXTENT OF CELL GROWTH |
33 |
101 |
4.233e-05 |
0.0002993 |
661 |
NEGATIVE REGULATION OF CELL ACTIVATION |
46 |
158 |
4.278e-05 |
0.0003011 |
662 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
159 |
724 |
4.31e-05 |
0.000303 |
663 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
21 |
53 |
4.492e-05 |
0.0003153 |
664 |
DENDRITE MORPHOGENESIS |
18 |
42 |
4.544e-05 |
0.0003185 |
665 |
CELLULAR RESPONSE TO BIOTIC STIMULUS |
47 |
163 |
4.637e-05 |
0.0003245 |
666 |
EXOCYTOSIS |
78 |
310 |
4.663e-05 |
0.0003258 |
667 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION |
11 |
19 |
4.707e-05 |
0.0003259 |
668 |
POSITIVE REGULATION OF MUSCLE HYPERTROPHY |
12 |
22 |
4.713e-05 |
0.0003259 |
669 |
REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL |
11 |
19 |
4.707e-05 |
0.0003259 |
670 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
12 |
22 |
4.713e-05 |
0.0003259 |
671 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
11 |
19 |
4.707e-05 |
0.0003259 |
672 |
GLOMERULAR EPITHELIUM DEVELOPMENT |
11 |
19 |
4.707e-05 |
0.0003259 |
673 |
POSITIVE REGULATION OF CARDIAC MUSCLE HYPERTROPHY |
12 |
22 |
4.713e-05 |
0.0003259 |
674 |
POST EMBRYONIC DEVELOPMENT |
30 |
89 |
4.818e-05 |
0.0003326 |
675 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
90 |
370 |
5.008e-05 |
0.0003452 |
676 |
POSITIVE REGULATION OF SYNAPSE ASSEMBLY |
23 |
61 |
5.023e-05 |
0.0003458 |
677 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
19 |
46 |
5.22e-05 |
0.0003588 |
678 |
POSITIVE REGULATION OF AXONOGENESIS |
25 |
69 |
5.237e-05 |
0.0003589 |
679 |
RESPONSE TO ACTIVITY |
25 |
69 |
5.237e-05 |
0.0003589 |
680 |
HINDBRAIN DEVELOPMENT |
41 |
137 |
5.486e-05 |
0.0003754 |
681 |
SALIVARY GLAND DEVELOPMENT |
15 |
32 |
5.527e-05 |
0.0003771 |
682 |
NEGATIVE REGULATION OF LEUKOCYTE MIGRATION |
15 |
32 |
5.527e-05 |
0.0003771 |
683 |
GLYCEROLIPID METABOLIC PROCESS |
87 |
356 |
5.545e-05 |
0.0003777 |
684 |
RESPONSE TO ESTRADIOL |
43 |
146 |
5.557e-05 |
0.000378 |
685 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
178 |
829 |
5.754e-05 |
0.0003909 |
686 |
REGULATION OF ORGANIC ACID TRANSPORT |
20 |
50 |
5.782e-05 |
0.0003922 |
687 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
35 |
111 |
5.799e-05 |
0.0003928 |
688 |
REGULATION OF NEURON APOPTOTIC PROCESS |
53 |
192 |
5.812e-05 |
0.000393 |
689 |
REGULATION OF ANION TRANSPORT |
41 |
138 |
6.584e-05 |
0.0004446 |
690 |
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
27 |
78 |
6.719e-05 |
0.0004524 |
691 |
RENAL TUBULE DEVELOPMENT |
27 |
78 |
6.719e-05 |
0.0004524 |
692 |
FOREBRAIN GENERATION OF NEURONS |
24 |
66 |
6.867e-05 |
0.0004611 |
693 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
24 |
66 |
6.867e-05 |
0.0004611 |
694 |
GLUCOSE HOMEOSTASIS |
48 |
170 |
6.912e-05 |
0.0004628 |
695 |
CARBOHYDRATE HOMEOSTASIS |
48 |
170 |
6.912e-05 |
0.0004628 |
696 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
32 |
99 |
6.948e-05 |
0.0004645 |
697 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
38 |
125 |
6.965e-05 |
0.0004649 |
698 |
NEUROMUSCULAR JUNCTION DEVELOPMENT |
16 |
36 |
7.022e-05 |
0.0004668 |
699 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
16 |
36 |
7.022e-05 |
0.0004668 |
700 |
LEUKOCYTE CELL CELL ADHESION |
66 |
255 |
7.011e-05 |
0.0004668 |
701 |
RESPONSE TO AMINO ACID |
35 |
112 |
7.12e-05 |
0.0004726 |
702 |
INTERACTION WITH HOST |
40 |
134 |
7.154e-05 |
0.0004742 |
703 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
108 |
465 |
7.386e-05 |
0.0004889 |
704 |
ION TRANSMEMBRANE TRANSPORT |
176 |
822 |
7.403e-05 |
0.0004893 |
705 |
LIPID METABOLIC PROCESS |
238 |
1158 |
7.427e-05 |
0.0004901 |
706 |
GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT |
13 |
26 |
7.521e-05 |
0.000495 |
707 |
REGULATION OF AMINO ACID TRANSPORT |
13 |
26 |
7.521e-05 |
0.000495 |
708 |
POSITIVE REGULATION OF METANEPHROS DEVELOPMENT |
9 |
14 |
7.68e-05 |
0.0005019 |
709 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
9 |
14 |
7.68e-05 |
0.0005019 |
710 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
9 |
14 |
7.68e-05 |
0.0005019 |
711 |
VOCALIZATION BEHAVIOR |
9 |
14 |
7.68e-05 |
0.0005019 |
712 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
9 |
14 |
7.68e-05 |
0.0005019 |
713 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
53 |
194 |
7.83e-05 |
0.000511 |
714 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
61 |
232 |
7.993e-05 |
0.0005209 |
715 |
TISSUE REMODELING |
29 |
87 |
8.04e-05 |
0.0005232 |
716 |
LEUKOCYTE CHEMOTAXIS |
36 |
117 |
8.099e-05 |
0.0005258 |
717 |
NEGATIVE REGULATION OF NEURON DEATH |
48 |
171 |
8.102e-05 |
0.0005258 |
718 |
RESPONSE TO CAMP |
33 |
104 |
8.118e-05 |
0.0005261 |
719 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
87 |
360 |
8.463e-05 |
0.0005477 |
720 |
NEURON RECOGNITION |
15 |
33 |
8.602e-05 |
0.0005559 |
721 |
REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION |
11 |
20 |
8.908e-05 |
0.0005733 |
722 |
RELAXATION OF MUSCLE |
11 |
20 |
8.908e-05 |
0.0005733 |
723 |
MELANOCYTE DIFFERENTIATION |
11 |
20 |
8.908e-05 |
0.0005733 |
724 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
52 |
191 |
0.0001002 |
0.0006441 |
725 |
REGULATION OF COAGULATION |
29 |
88 |
0.0001013 |
0.0006494 |
726 |
REGULATION OF CATION CHANNEL ACTIVITY |
29 |
88 |
0.0001013 |
0.0006494 |
727 |
CELLULAR LIPID METABOLIC PROCESS |
192 |
913 |
0.0001021 |
0.0006536 |
728 |
CORONARY VASCULATURE DEVELOPMENT |
16 |
37 |
0.000105 |
0.0006691 |
729 |
IMPORT INTO CELL |
16 |
37 |
0.000105 |
0.0006691 |
730 |
AXON EXTENSION |
16 |
37 |
0.000105 |
0.0006691 |
731 |
NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE |
20 |
52 |
0.0001109 |
0.0007058 |
732 |
FORMATION OF PRIMARY GERM LAYER |
34 |
110 |
0.0001142 |
0.0007257 |
733 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
21 |
56 |
0.0001155 |
0.000733 |
734 |
POSITIVE REGULATION OF PROTEIN SECRETION |
56 |
211 |
0.0001172 |
0.0007429 |
735 |
REGULATION OF PHAGOCYTOSIS |
24 |
68 |
0.0001183 |
0.0007491 |
736 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
23 |
64 |
0.0001189 |
0.0007519 |
737 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
17 |
41 |
0.0001212 |
0.0007652 |
738 |
ACTIVATION OF PHOSPHOLIPASE C ACTIVITY |
13 |
27 |
0.0001233 |
0.0007755 |
739 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
13 |
27 |
0.0001233 |
0.0007755 |
740 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
13 |
27 |
0.0001233 |
0.0007755 |
741 |
REGULATION OF CELL CYCLE |
198 |
949 |
0.0001268 |
0.0007963 |
742 |
FOREBRAIN NEURON DEVELOPMENT |
15 |
34 |
0.0001307 |
0.0008196 |
743 |
NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS |
32 |
102 |
0.0001313 |
0.0008222 |
744 |
THYMOCYTE AGGREGATION |
18 |
45 |
0.0001343 |
0.0008375 |
745 |
EXOCRINE SYSTEM DEVELOPMENT |
18 |
45 |
0.0001343 |
0.0008375 |
746 |
T CELL DIFFERENTIATION IN THYMUS |
18 |
45 |
0.0001343 |
0.0008375 |
747 |
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS |
8 |
12 |
0.0001371 |
0.0008519 |
748 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS |
8 |
12 |
0.0001371 |
0.0008519 |
749 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
8 |
12 |
0.0001371 |
0.0008519 |
750 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
27 |
81 |
0.0001396 |
0.0008651 |
751 |
REGULATION OF JUN KINASE ACTIVITY |
27 |
81 |
0.0001396 |
0.0008651 |
752 |
POSITIVE REGULATION OF RECEPTOR INTERNALIZATION |
12 |
24 |
0.0001427 |
0.0008807 |
753 |
EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
12 |
24 |
0.0001427 |
0.0008807 |
754 |
NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
12 |
24 |
0.0001427 |
0.0008807 |
755 |
ACTIN FILAMENT BUNDLE ORGANIZATION |
19 |
49 |
0.0001441 |
0.0008881 |
756 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
38 |
129 |
0.0001455 |
0.0008957 |
757 |
RESPONSE TO BMP |
30 |
94 |
0.0001493 |
0.0009165 |
758 |
CELLULAR RESPONSE TO BMP STIMULUS |
30 |
94 |
0.0001493 |
0.0009165 |
759 |
CELLULAR RESPONSE TO KETONE |
25 |
73 |
0.0001499 |
0.0009188 |
760 |
REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS |
20 |
53 |
0.0001509 |
0.0009212 |
761 |
CYTOSOLIC CALCIUM ION TRANSPORT |
20 |
53 |
0.0001509 |
0.0009212 |
762 |
MESONEPHRIC TUBULE MORPHOGENESIS |
20 |
53 |
0.0001509 |
0.0009212 |
763 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
43 |
152 |
0.0001532 |
0.0009342 |
764 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
16 |
38 |
0.0001539 |
0.0009372 |
765 |
CELLULAR RESPONSE TO RETINOIC ACID |
23 |
65 |
0.0001558 |
0.0009475 |
766 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
22 |
61 |
0.0001563 |
0.0009496 |
767 |
NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT |
41 |
143 |
0.0001569 |
0.0009516 |
768 |
LIPID TRANSLOCATION |
11 |
21 |
0.0001594 |
0.0009643 |
769 |
POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
11 |
21 |
0.0001594 |
0.0009643 |
770 |
REGULATION OF CIRCADIAN RHYTHM |
32 |
103 |
0.0001609 |
0.0009707 |
771 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
14 |
31 |
0.0001611 |
0.0009707 |
772 |
REGULATION OF SYNAPTIC VESICLE TRANSPORT |
14 |
31 |
0.0001611 |
0.0009707 |
773 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
9 |
15 |
0.000164 |
0.0009871 |
774 |
RESPONSE TO PLATELET DERIVED GROWTH FACTOR |
10 |
18 |
0.0001687 |
0.001014 |
775 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
60 |
233 |
0.0001694 |
0.001017 |
776 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
17 |
42 |
0.0001727 |
0.001034 |
777 |
NEGATIVE REGULATION OF IMMUNE RESPONSE |
36 |
121 |
0.0001726 |
0.001034 |
778 |
POSITIVE REGULATION OF RESPONSE TO WOUNDING |
45 |
162 |
0.000173 |
0.001035 |
779 |
KIDNEY MORPHOGENESIS |
27 |
82 |
0.000176 |
0.001051 |
780 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
43 |
153 |
0.0001797 |
0.001072 |
781 |
NEGATIVE REGULATION OF PROTEIN SECRETION |
33 |
108 |
0.0001821 |
0.001085 |
782 |
PEPTIDYL THREONINE MODIFICATION |
18 |
46 |
0.000187 |
0.001111 |
783 |
POSITIVE REGULATION OF PHAGOCYTOSIS |
18 |
46 |
0.000187 |
0.001111 |
784 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
39 |
135 |
0.0001885 |
0.001119 |
785 |
HORMONE MEDIATED SIGNALING PATHWAY |
44 |
158 |
0.0001908 |
0.001131 |
786 |
REGULATION OF ACUTE INFLAMMATORY RESPONSE |
25 |
74 |
0.0001915 |
0.001133 |
787 |
POSITIVE REGULATION OF HEART CONTRACTION |
15 |
35 |
0.0001942 |
0.001147 |
788 |
RESPONSE TO MINERALOCORTICOID |
15 |
35 |
0.0001942 |
0.001147 |
789 |
GLUTAMATE SECRETION |
13 |
28 |
0.0001958 |
0.001152 |
790 |
REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
13 |
28 |
0.0001958 |
0.001152 |
791 |
REGULATION OF FATTY ACID OXIDATION |
13 |
28 |
0.0001958 |
0.001152 |
792 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
19 |
50 |
0.000197 |
0.001156 |
793 |
RHO PROTEIN SIGNAL TRANSDUCTION |
19 |
50 |
0.000197 |
0.001156 |
794 |
NEURAL PRECURSOR CELL PROLIFERATION |
24 |
70 |
0.0001977 |
0.001158 |
795 |
TRANSMISSION OF NERVE IMPULSE |
20 |
54 |
0.000203 |
0.001187 |
796 |
VENTRICULAR SEPTUM DEVELOPMENT |
20 |
54 |
0.000203 |
0.001187 |
797 |
CARDIAC VENTRICLE MORPHOGENESIS |
22 |
62 |
0.0002052 |
0.001198 |
798 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
109 |
482 |
0.000208 |
0.001213 |
799 |
REGULATION OF FATTY ACID METABOLIC PROCESS |
28 |
87 |
0.0002086 |
0.001215 |
800 |
PHOSPHOLIPID METABOLIC PROCESS |
86 |
364 |
0.0002099 |
0.001221 |
801 |
LIMBIC SYSTEM DEVELOPMENT |
31 |
100 |
0.0002112 |
0.001227 |
802 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
92 |
395 |
0.0002192 |
0.001272 |
803 |
REGULATION OF AXON GUIDANCE |
16 |
39 |
0.0002215 |
0.001282 |
804 |
LONG TERM SYNAPTIC POTENTIATION |
16 |
39 |
0.0002215 |
0.001282 |
805 |
CALCIUM ION TRANSMEMBRANE TRANSPORT |
44 |
159 |
0.0002226 |
0.001286 |
806 |
POSITIVE REGULATION OF BINDING |
37 |
127 |
0.0002257 |
0.001302 |
807 |
REGULATION OF CELL CELL ADHESION |
89 |
380 |
0.0002256 |
0.001302 |
808 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
56 |
216 |
0.0002272 |
0.001308 |
809 |
REGULATION OF LEUKOCYTE APOPTOTIC PROCESS |
26 |
79 |
0.0002321 |
0.001335 |
810 |
CELLULAR EXTRAVASATION |
12 |
25 |
0.0002336 |
0.00134 |
811 |
POSTSYNAPTIC MEMBRANE ORGANIZATION |
12 |
25 |
0.0002336 |
0.00134 |
812 |
CEREBRAL CORTEX CELL MIGRATION |
17 |
43 |
0.0002423 |
0.001389 |
813 |
REGULATION OF ORGAN FORMATION |
14 |
32 |
0.0002433 |
0.001391 |
814 |
ADIPOSE TISSUE DEVELOPMENT |
14 |
32 |
0.0002433 |
0.001391 |
815 |
NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
24 |
71 |
0.0002527 |
0.001441 |
816 |
ADHERENS JUNCTION ORGANIZATION |
24 |
71 |
0.0002527 |
0.001441 |
817 |
CELLULAR RESPONSE TO DRUG |
23 |
67 |
0.0002609 |
0.001486 |
818 |
HOMOTYPIC CELL CELL ADHESION |
19 |
51 |
0.0002661 |
0.001514 |
819 |
NEGATIVE REGULATION OF MUSCLE CONTRACTION |
11 |
22 |
0.0002716 |
0.001534 |
820 |
BONE CELL DEVELOPMENT |
11 |
22 |
0.0002716 |
0.001534 |
821 |
POSITIVE REGULATION OF HEART RATE |
11 |
22 |
0.0002716 |
0.001534 |
822 |
POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION |
11 |
22 |
0.0002716 |
0.001534 |
823 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
20 |
55 |
0.0002703 |
0.001534 |
824 |
SUBPALLIUM DEVELOPMENT |
11 |
22 |
0.0002716 |
0.001534 |
825 |
NEGATIVE REGULATION OF BLOOD CIRCULATION |
15 |
36 |
0.0002828 |
0.001591 |
826 |
OLFACTORY LOBE DEVELOPMENT |
15 |
36 |
0.0002828 |
0.001591 |
827 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
15 |
36 |
0.0002828 |
0.001591 |
828 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
32 |
106 |
0.0002887 |
0.001622 |
829 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
26 |
80 |
0.0002909 |
0.001633 |
830 |
REGULATION OF DNA BINDING |
29 |
93 |
0.0002979 |
0.00167 |
831 |
NEGATIVE REGULATION OF RECEPTOR ACTIVITY |
13 |
29 |
0.0003018 |
0.00169 |
832 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
10 |
19 |
0.0003039 |
0.001692 |
833 |
FIBRIL ORGANIZATION |
10 |
19 |
0.0003039 |
0.001692 |
834 |
RELAXATION OF CARDIAC MUSCLE |
8 |
13 |
0.0003051 |
0.001692 |
835 |
KIDNEY VASCULATURE DEVELOPMENT |
10 |
19 |
0.0003039 |
0.001692 |
836 |
RENAL SYSTEM VASCULATURE DEVELOPMENT |
10 |
19 |
0.0003039 |
0.001692 |
837 |
MESENCHYMAL CELL PROLIFERATION |
8 |
13 |
0.0003051 |
0.001692 |
838 |
NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS |
8 |
13 |
0.0003051 |
0.001692 |
839 |
EXTRACELLULAR FIBRIL ORGANIZATION |
8 |
13 |
0.0003051 |
0.001692 |
840 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
25 |
76 |
0.0003063 |
0.001697 |
841 |
MAMMARY GLAND MORPHOGENESIS |
16 |
40 |
0.0003133 |
0.001729 |
842 |
FORELIMB MORPHOGENESIS |
16 |
40 |
0.0003133 |
0.001729 |
843 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
16 |
40 |
0.0003133 |
0.001729 |
844 |
REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
9 |
16 |
0.0003203 |
0.001761 |
845 |
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS |
9 |
16 |
0.0003203 |
0.001761 |
846 |
REGULATION OF FATTY ACID BETA OXIDATION |
9 |
16 |
0.0003203 |
0.001761 |
847 |
NERVE DEVELOPMENT |
23 |
68 |
0.0003337 |
0.001833 |
848 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
17 |
44 |
0.0003351 |
0.001839 |
849 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
38 |
134 |
0.0003407 |
0.001867 |
850 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
22 |
64 |
0.0003444 |
0.001886 |
851 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
19 |
52 |
0.0003555 |
0.001944 |
852 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
20 |
56 |
0.0003563 |
0.001946 |
853 |
POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS |
14 |
33 |
0.0003592 |
0.00196 |
854 |
NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT |
12 |
26 |
0.0003694 |
0.00201 |
855 |
RESPONSE TO CORTICOSTERONE |
12 |
26 |
0.0003694 |
0.00201 |
856 |
REGULATION OF CYTOKINE PRODUCTION |
123 |
563 |
0.0003777 |
0.002053 |
857 |
REGULATION OF PROTEIN KINASE B SIGNALING |
35 |
121 |
0.0003816 |
0.002072 |
858 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
25 |
77 |
0.0003838 |
0.002079 |
859 |
REGULATION OF BMP SIGNALING PATHWAY |
25 |
77 |
0.0003838 |
0.002079 |
860 |
NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
38 |
135 |
0.0004003 |
0.002166 |
861 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
24 |
73 |
0.0004045 |
0.002183 |
862 |
POSITIVE REGULATION OF CATION CHANNEL ACTIVITY |
15 |
37 |
0.0004041 |
0.002183 |
863 |
STRIATED MUSCLE CONTRACTION |
30 |
99 |
0.0004097 |
0.002209 |
864 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
34 |
117 |
0.000418 |
0.002248 |
865 |
MAMMARY GLAND DEVELOPMENT |
34 |
117 |
0.000418 |
0.002248 |
866 |
AORTA DEVELOPMENT |
16 |
41 |
0.0004363 |
0.002344 |
867 |
CALCIUM ION IMPORT |
22 |
65 |
0.000441 |
0.002358 |
868 |
CELL MATURATION |
37 |
131 |
0.0004408 |
0.002358 |
869 |
REGULATION OF RESPONSE TO OXIDATIVE STRESS |
22 |
65 |
0.000441 |
0.002358 |
870 |
NEGATIVE REGULATION OF AXONOGENESIS |
22 |
65 |
0.000441 |
0.002358 |
871 |
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
11 |
23 |
0.0004437 |
0.002362 |
872 |
REGULATION OF OSTEOBLAST PROLIFERATION |
11 |
23 |
0.0004437 |
0.002362 |
873 |
STRIATED MUSCLE ADAPTATION |
11 |
23 |
0.0004437 |
0.002362 |
874 |
INNERVATION |
11 |
23 |
0.0004437 |
0.002362 |
875 |
RECEPTOR METABOLIC PROCESS |
26 |
82 |
0.0004489 |
0.002387 |
876 |
NEURON MATURATION |
13 |
30 |
0.0004531 |
0.002396 |
877 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
13 |
30 |
0.0004531 |
0.002396 |
878 |
NEGATIVE REGULATION OF CELL MATRIX ADHESION |
13 |
30 |
0.0004531 |
0.002396 |
879 |
MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
13 |
30 |
0.0004531 |
0.002396 |
880 |
ESTABLISHMENT OF ENDOTHELIAL BARRIER |
13 |
30 |
0.0004531 |
0.002396 |
881 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
31 |
104 |
0.000455 |
0.002403 |
882 |
POSITIVE REGULATION OF RECEPTOR ACTIVITY |
17 |
45 |
0.000457 |
0.002411 |
883 |
CIRCADIAN REGULATION OF GENE EXPRESSION |
20 |
57 |
0.0004652 |
0.002448 |
884 |
AMMONIUM TRANSPORT |
20 |
57 |
0.0004652 |
0.002448 |
885 |
CARDIAC SEPTUM MORPHOGENESIS |
18 |
49 |
0.0004676 |
0.002459 |
886 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
19 |
53 |
0.0004698 |
0.002462 |
887 |
NEURON PROJECTION EXTENSION |
19 |
53 |
0.0004698 |
0.002462 |
888 |
NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
38 |
136 |
0.000469 |
0.002462 |
889 |
METENCEPHALON DEVELOPMENT |
30 |
100 |
0.0004947 |
0.002589 |
890 |
MESODERM DEVELOPMENT |
34 |
118 |
0.000496 |
0.002593 |
891 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
73 |
307 |
0.000498 |
0.002601 |
892 |
RESPONSE TO HYDROGEN PEROXIDE |
32 |
109 |
0.0004999 |
0.002608 |
893 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
24 |
74 |
0.0005067 |
0.002634 |
894 |
NEGATIVE REGULATION OF HORMONE SECRETION |
24 |
74 |
0.0005067 |
0.002634 |
895 |
CELL CELL JUNCTION ASSEMBLY |
24 |
74 |
0.0005067 |
0.002634 |
896 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
14 |
34 |
0.0005192 |
0.002687 |
897 |
NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY |
10 |
20 |
0.0005186 |
0.002687 |
898 |
OLIGODENDROCYTE DEVELOPMENT |
14 |
34 |
0.0005192 |
0.002687 |
899 |
MICROVILLUS ORGANIZATION |
10 |
20 |
0.0005186 |
0.002687 |
900 |
MYELOID LEUKOCYTE DIFFERENTIATION |
29 |
96 |
0.000537 |
0.002773 |
901 |
REGULATION OF LEUKOCYTE CHEMOTAXIS |
29 |
96 |
0.000537 |
0.002773 |
902 |
ACTIVATION OF MAPK ACTIVITY |
38 |
137 |
0.000548 |
0.002827 |
903 |
ORGAN REGENERATION |
26 |
83 |
0.0005531 |
0.002847 |
904 |
RESPONSE TO FATTY ACID |
26 |
83 |
0.0005531 |
0.002847 |
905 |
CARDIAC MUSCLE ADAPTATION |
7 |
11 |
0.0005647 |
0.002892 |
906 |
EXCITATORY POSTSYNAPTIC POTENTIAL |
12 |
27 |
0.0005662 |
0.002892 |
907 |
REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL |
7 |
11 |
0.0005647 |
0.002892 |
908 |
MUSCLE HYPERTROPHY IN RESPONSE TO STRESS |
7 |
11 |
0.0005647 |
0.002892 |
909 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
12 |
27 |
0.0005662 |
0.002892 |
910 |
POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
12 |
27 |
0.0005662 |
0.002892 |
911 |
CARDIAC MUSCLE HYPERTROPHY IN RESPONSE TO STRESS |
7 |
11 |
0.0005647 |
0.002892 |
912 |
REGULATION OF PHOSPHATASE ACTIVITY |
36 |
128 |
0.0005701 |
0.002907 |
913 |
REGULATION OF LEUKOCYTE MEDIATED IMMUNITY |
42 |
156 |
0.0005703 |
0.002907 |
914 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
9 |
17 |
0.0005817 |
0.002951 |
915 |
EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS |
9 |
17 |
0.0005817 |
0.002951 |
916 |
NEGATIVE REGULATION OF LIPID STORAGE |
9 |
17 |
0.0005817 |
0.002951 |
917 |
DEFINITIVE HEMOPOIESIS |
9 |
17 |
0.0005817 |
0.002951 |
918 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
16 |
42 |
0.0005985 |
0.003034 |
919 |
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
8 |
14 |
0.0006095 |
0.003063 |
920 |
EPITHELIAL CELL CELL ADHESION |
8 |
14 |
0.0006095 |
0.003063 |
921 |
REGULATION OF GLOMERULUS DEVELOPMENT |
8 |
14 |
0.0006095 |
0.003063 |
922 |
METANEPHRIC MESENCHYME DEVELOPMENT |
8 |
14 |
0.0006095 |
0.003063 |
923 |
POSITIVE REGULATION OF CELL SIZE |
8 |
14 |
0.0006095 |
0.003063 |
924 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
8 |
14 |
0.0006095 |
0.003063 |
925 |
CAMP CATABOLIC PROCESS |
8 |
14 |
0.0006095 |
0.003063 |
926 |
REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY |
8 |
14 |
0.0006095 |
0.003063 |
927 |
PROTEIN DEPHOSPHORYLATION |
49 |
190 |
0.0006139 |
0.003081 |
928 |
POSITIVE REGULATION OF CALCIUM ION IMPORT |
19 |
54 |
0.0006147 |
0.003082 |
929 |
VISUAL BEHAVIOR |
18 |
50 |
0.0006199 |
0.003105 |
930 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
24 |
75 |
0.0006309 |
0.003153 |
931 |
NEGATIVE REGULATION OF CELL CYCLE |
97 |
433 |
0.0006304 |
0.003153 |
932 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
26 |
84 |
0.0006778 |
0.003384 |
933 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
182 |
891 |
0.0006958 |
0.00347 |
934 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
11 |
24 |
0.0006984 |
0.003479 |
935 |
INSULIN RECEPTOR SIGNALING PATHWAY |
25 |
80 |
0.0007286 |
0.003626 |
936 |
EMBRYONIC CAMERA TYPE EYE DEVELOPMENT |
14 |
35 |
0.0007359 |
0.003654 |
937 |
REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES |
14 |
35 |
0.0007359 |
0.003654 |
938 |
EPITHELIAL CELL PROLIFERATION |
27 |
89 |
0.0007635 |
0.003788 |
939 |
REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS |
20 |
59 |
0.0007718 |
0.003825 |
940 |
AMINOGLYCAN BIOSYNTHETIC PROCESS |
31 |
107 |
0.0007759 |
0.003841 |
941 |
MYELOID LEUKOCYTE ACTIVATION |
29 |
98 |
0.000778 |
0.003847 |
942 |
POSITIVE REGULATION OF HEMOPOIESIS |
43 |
163 |
0.0007804 |
0.003852 |
943 |
GLIAL CELL DEVELOPMENT |
24 |
76 |
0.0007806 |
0.003852 |
944 |
TRABECULA MORPHOGENESIS |
15 |
39 |
0.0007833 |
0.003853 |
945 |
REGULATION OF MAST CELL ACTIVATION |
15 |
39 |
0.0007833 |
0.003853 |
946 |
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION |
15 |
39 |
0.0007833 |
0.003853 |
947 |
RESPONSE TO EXTRACELLULAR STIMULUS |
98 |
441 |
0.0007869 |
0.003866 |
948 |
NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
19 |
55 |
0.0007965 |
0.003909 |
949 |
NEURAL TUBE DEVELOPMENT |
40 |
149 |
0.0008086 |
0.003965 |
950 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
16 |
43 |
0.0008096 |
0.003965 |
951 |
POSITIVE REGULATION OF DEPHOSPHORYLATION |
17 |
47 |
0.0008183 |
0.004004 |
952 |
REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION |
26 |
85 |
0.0008264 |
0.004039 |
953 |
NEURONAL ACTION POTENTIAL |
12 |
28 |
0.0008441 |
0.004113 |
954 |
PURINERGIC RECEPTOR SIGNALING PATHWAY |
12 |
28 |
0.0008441 |
0.004113 |
955 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
12 |
28 |
0.0008441 |
0.004113 |
956 |
REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS |
10 |
21 |
0.0008453 |
0.004114 |
957 |
NEURAL TUBE FORMATION |
28 |
94 |
0.000848 |
0.004123 |
958 |
OSTEOBLAST DIFFERENTIATION |
35 |
126 |
0.0008621 |
0.004187 |
959 |
IMMUNE RESPONSE |
219 |
1100 |
0.0008844 |
0.004291 |
960 |
PHENOL CONTAINING COMPOUND METABOLIC PROCESS |
25 |
81 |
0.0008921 |
0.004324 |
961 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
85 |
375 |
0.0009091 |
0.004397 |
962 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
36 |
131 |
0.0009089 |
0.004397 |
963 |
NEGATIVE REGULATION OF CATABOLIC PROCESS |
51 |
203 |
0.0009159 |
0.004426 |
964 |
REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
31 |
108 |
0.0009201 |
0.004441 |
965 |
SINGLE ORGANISM CATABOLIC PROCESS |
193 |
957 |
0.0009335 |
0.004501 |
966 |
EMBRYONIC FORELIMB MORPHOGENESIS |
13 |
32 |
0.000952 |
0.004576 |
967 |
METANEPHRIC NEPHRON DEVELOPMENT |
13 |
32 |
0.000952 |
0.004576 |
968 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
63 |
263 |
0.0009517 |
0.004576 |
969 |
NEUROTRANSMITTER TRANSPORT |
41 |
155 |
0.0009628 |
0.004623 |
970 |
LEUKOCYTE HOMEOSTASIS |
20 |
60 |
0.0009816 |
0.004709 |
971 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
9 |
18 |
0.0009946 |
0.004756 |
972 |
KIDNEY MESENCHYME DEVELOPMENT |
9 |
18 |
0.0009946 |
0.004756 |
973 |
INOSITOL PHOSPHATE MEDIATED SIGNALING |
9 |
18 |
0.0009946 |
0.004756 |
974 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
14 |
36 |
0.001024 |
0.004868 |
975 |
INOSITOL PHOSPHATE METABOLIC PROCESS |
19 |
56 |
0.001022 |
0.004868 |
976 |
POSITIVE REGULATION OF AXON EXTENSION |
14 |
36 |
0.001024 |
0.004868 |
977 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
14 |
36 |
0.001024 |
0.004868 |
978 |
CORTICAL CYTOSKELETON ORGANIZATION |
14 |
36 |
0.001024 |
0.004868 |
979 |
HEAD MORPHOGENESIS |
14 |
36 |
0.001024 |
0.004868 |
980 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
23 |
73 |
0.00103 |
0.004892 |
981 |
TRANSMEMBRANE TRANSPORT |
218 |
1098 |
0.001051 |
0.004987 |
982 |
CELL PROJECTION ASSEMBLY |
63 |
264 |
0.001054 |
0.004992 |
983 |
REGULATION OF LIPID CATABOLIC PROCESS |
18 |
52 |
0.001055 |
0.004994 |
984 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
15 |
40 |
0.001065 |
0.005017 |
985 |
NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
15 |
40 |
0.001065 |
0.005017 |
986 |
DOPAMINE METABOLIC PROCESS |
11 |
25 |
0.001064 |
0.005017 |
987 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
15 |
40 |
0.001065 |
0.005017 |
988 |
POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
11 |
25 |
0.001064 |
0.005017 |
989 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
80 |
351 |
0.001068 |
0.005026 |
990 |
POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS |
17 |
48 |
0.001076 |
0.005046 |
991 |
REGULATION OF LIPID KINASE ACTIVITY |
17 |
48 |
0.001076 |
0.005046 |
992 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
17 |
48 |
0.001076 |
0.005046 |
993 |
POSITIVE REGULATION OF MUSCLE CONTRACTION |
16 |
44 |
0.001081 |
0.005064 |
994 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
25 |
82 |
0.001087 |
0.005086 |
995 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
29 |
100 |
0.001109 |
0.005184 |
996 |
NEUROTRANSMITTER UPTAKE |
8 |
15 |
0.001119 |
0.0052 |
997 |
REGULATION OF HEAT GENERATION |
8 |
15 |
0.001119 |
0.0052 |
998 |
NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS |
8 |
15 |
0.001119 |
0.0052 |
999 |
POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION |
8 |
15 |
0.001119 |
0.0052 |
1000 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
8 |
15 |
0.001119 |
0.0052 |
1001 |
VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL |
8 |
15 |
0.001119 |
0.0052 |
1002 |
REGULATION OF ORGANELLE ORGANIZATION |
232 |
1178 |
0.001149 |
0.005335 |
1003 |
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE |
7 |
12 |
0.001163 |
0.005354 |
1004 |
ROUNDABOUT SIGNALING PATHWAY |
7 |
12 |
0.001163 |
0.005354 |
1005 |
REGULATION OF BROWN FAT CELL DIFFERENTIATION |
7 |
12 |
0.001163 |
0.005354 |
1006 |
AXON EXTENSION INVOLVED IN AXON GUIDANCE |
7 |
12 |
0.001163 |
0.005354 |
1007 |
CENTRAL NERVOUS SYSTEM MYELINATION |
7 |
12 |
0.001163 |
0.005354 |
1008 |
AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM |
7 |
12 |
0.001163 |
0.005354 |
1009 |
VASCULAR SMOOTH MUSCLE CONTRACTION |
7 |
12 |
0.001163 |
0.005354 |
1010 |
REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY |
7 |
12 |
0.001163 |
0.005354 |
1011 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
7 |
12 |
0.001163 |
0.005354 |
1012 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
35 |
128 |
0.001169 |
0.005377 |
1013 |
REGULATION OF CHEMOKINE PRODUCTION |
21 |
65 |
0.001171 |
0.005378 |
1014 |
CYTOSOLIC TRANSPORT |
53 |
215 |
0.001172 |
0.005378 |
1015 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
39 |
147 |
0.001188 |
0.005446 |
1016 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
26 |
87 |
0.00121 |
0.005504 |
1017 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
26 |
87 |
0.00121 |
0.005504 |
1018 |
VIRAL ENTRY INTO HOST CELL |
26 |
87 |
0.00121 |
0.005504 |
1019 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
26 |
87 |
0.00121 |
0.005504 |
1020 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
26 |
87 |
0.00121 |
0.005504 |
1021 |
MOVEMENT IN HOST ENVIRONMENT |
26 |
87 |
0.00121 |
0.005504 |
1022 |
ENTRY INTO HOST |
26 |
87 |
0.00121 |
0.005504 |
1023 |
ENTRY INTO HOST CELL |
26 |
87 |
0.00121 |
0.005504 |
1024 |
STEM CELL DIVISION |
12 |
29 |
0.001227 |
0.005564 |
1025 |
MUSCLE ADAPTATION |
12 |
29 |
0.001227 |
0.005564 |
1026 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
12 |
29 |
0.001227 |
0.005564 |
1027 |
PEPTIDYL AMINO ACID MODIFICATION |
171 |
841 |
0.00123 |
0.005573 |
1028 |
MYOTUBE DIFFERENTIATION |
19 |
57 |
0.001301 |
0.005889 |
1029 |
POST GOLGI VESICLE MEDIATED TRANSPORT |
25 |
83 |
0.001316 |
0.005953 |
1030 |
PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY |
10 |
22 |
0.001323 |
0.005966 |
1031 |
SOMATIC STEM CELL DIVISION |
10 |
22 |
0.001323 |
0.005966 |
1032 |
ACTIVATION OF PROTEIN KINASE B ACTIVITY |
10 |
22 |
0.001323 |
0.005966 |
1033 |
NEGATIVE REGULATION OF ANION TRANSPORT |
13 |
33 |
0.001337 |
0.006018 |
1034 |
NEGATIVE REGULATION OF JNK CASCADE |
13 |
33 |
0.001337 |
0.006018 |
1035 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
18 |
53 |
0.001356 |
0.00609 |
1036 |
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION |
18 |
53 |
0.001356 |
0.00609 |
1037 |
MUSCLE ORGAN MORPHOGENESIS |
22 |
70 |
0.001361 |
0.006105 |
1038 |
PEPTIDYL SERINE MODIFICATION |
39 |
148 |
0.001362 |
0.006107 |
1039 |
HINDLIMB MORPHOGENESIS |
14 |
37 |
0.001402 |
0.006229 |
1040 |
MATING |
14 |
37 |
0.001402 |
0.006229 |
1041 |
ACTIN POLYMERIZATION OR DEPOLYMERIZATION |
14 |
37 |
0.001402 |
0.006229 |
1042 |
REGULATION OF MEMBRANE LIPID DISTRIBUTION |
14 |
37 |
0.001402 |
0.006229 |
1043 |
REGULATION OF RECEPTOR INTERNALIZATION |
14 |
37 |
0.001402 |
0.006229 |
1044 |
POSITIVE REGULATION OF CHEMOKINE PRODUCTION |
17 |
49 |
0.001399 |
0.006229 |
1045 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
40 |
153 |
0.001401 |
0.006229 |
1046 |
GLIAL CELL MIGRATION |
14 |
37 |
0.001402 |
0.006229 |
1047 |
CAMP MEDIATED SIGNALING |
14 |
37 |
0.001402 |
0.006229 |
1048 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
64 |
272 |
0.001409 |
0.006257 |
1049 |
SPINAL CORD DEVELOPMENT |
30 |
106 |
0.001411 |
0.006259 |
1050 |
REGULATION OF LIPID STORAGE |
15 |
41 |
0.001428 |
0.006293 |
1051 |
LUNG MORPHOGENESIS |
16 |
45 |
0.001425 |
0.006293 |
1052 |
GOLGI TO PLASMA MEMBRANE TRANSPORT |
15 |
41 |
0.001428 |
0.006293 |
1053 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
15 |
41 |
0.001428 |
0.006293 |
1054 |
HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
16 |
45 |
0.001425 |
0.006293 |
1055 |
ENDOCHONDRAL BONE MORPHOGENESIS |
16 |
45 |
0.001425 |
0.006293 |
1056 |
PROSTATE GLAND DEVELOPMENT |
15 |
41 |
0.001428 |
0.006293 |
1057 |
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS |
33 |
120 |
0.001434 |
0.006305 |
1058 |
CYTOKINE PRODUCTION |
33 |
120 |
0.001434 |
0.006305 |
1059 |
REGULATION OF DEPHOSPHORYLATION |
41 |
158 |
0.001437 |
0.006314 |
1060 |
NEUROMUSCULAR PROCESS |
28 |
97 |
0.001445 |
0.006344 |
1061 |
ACID SECRETION |
21 |
66 |
0.001456 |
0.006373 |
1062 |
MESODERM MORPHOGENESIS |
21 |
66 |
0.001456 |
0.006373 |
1063 |
POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
26 |
88 |
0.001454 |
0.006373 |
1064 |
INORGANIC ION TRANSMEMBRANE TRANSPORT |
123 |
583 |
0.001499 |
0.006557 |
1065 |
SIGNAL RELEASE |
44 |
173 |
0.001523 |
0.006656 |
1066 |
NEGATIVE REGULATION OF HYDROLASE ACTIVITY |
88 |
397 |
0.001528 |
0.006668 |
1067 |
SENSORY PERCEPTION OF PAIN |
23 |
75 |
0.001547 |
0.006748 |
1068 |
VASODILATION |
11 |
26 |
0.001573 |
0.006832 |
1069 |
REGULATION OF REGULATED SECRETORY PATHWAY |
35 |
130 |
0.001568 |
0.006832 |
1070 |
ENTRAINMENT OF CIRCADIAN CLOCK |
11 |
26 |
0.001573 |
0.006832 |
1071 |
NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT |
11 |
26 |
0.001573 |
0.006832 |
1072 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
47 |
188 |
0.001582 |
0.006867 |
1073 |
POSITIVE REGULATION OF BLOOD CIRCULATION |
27 |
93 |
0.001586 |
0.006876 |
1074 |
CYTOKINESIS |
25 |
84 |
0.001587 |
0.006876 |
1075 |
PROTEIN HOMOOLIGOMERIZATION |
59 |
248 |
0.001607 |
0.006956 |
1076 |
ENTRAINMENT OF CIRCADIAN CLOCK BY PHOTOPERIOD |
9 |
19 |
0.001616 |
0.006976 |
1077 |
REGULATION OF LONG TERM SYNAPTIC POTENTIATION |
9 |
19 |
0.001616 |
0.006976 |
1078 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
9 |
19 |
0.001616 |
0.006976 |
1079 |
RESPONSE TO RETINOIC ACID |
30 |
107 |
0.001659 |
0.007152 |
1080 |
SKIN EPIDERMIS DEVELOPMENT |
22 |
71 |
0.001671 |
0.007199 |
1081 |
REGULATION OF DEFENSE RESPONSE |
155 |
759 |
0.001693 |
0.007279 |
1082 |
REGULATION OF IMMUNE RESPONSE |
173 |
858 |
0.001692 |
0.007279 |
1083 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
28 |
98 |
0.001712 |
0.007355 |
1084 |
ADULT LOCOMOTORY BEHAVIOR |
24 |
80 |
0.001729 |
0.007423 |
1085 |
CEREBELLAR CORTEX MORPHOGENESIS |
12 |
30 |
0.001743 |
0.007453 |
1086 |
NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY |
12 |
30 |
0.001743 |
0.007453 |
1087 |
OSTEOCLAST DIFFERENTIATION |
12 |
30 |
0.001743 |
0.007453 |
1088 |
REGULATION OF VASCULAR PERMEABILITY |
12 |
30 |
0.001743 |
0.007453 |
1089 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
180 |
898 |
0.001809 |
0.007731 |
1090 |
STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
29 |
103 |
0.001831 |
0.007816 |
1091 |
ADHERENS JUNCTION ASSEMBLY |
13 |
34 |
0.001844 |
0.007863 |
1092 |
INTRASPECIES INTERACTION BETWEEN ORGANISMS |
16 |
46 |
0.001857 |
0.007897 |
1093 |
SOCIAL BEHAVIOR |
16 |
46 |
0.001857 |
0.007897 |
1094 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
16 |
46 |
0.001857 |
0.007897 |
1095 |
CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL |
15 |
42 |
0.001889 |
0.007998 |
1096 |
CATECHOLAMINE METABOLIC PROCESS |
15 |
42 |
0.001889 |
0.007998 |
1097 |
EPITHELIAL CELL MORPHOGENESIS |
15 |
42 |
0.001889 |
0.007998 |
1098 |
CATECHOL CONTAINING COMPOUND METABOLIC PROCESS |
15 |
42 |
0.001889 |
0.007998 |
1099 |
CALCIUM ION IMPORT INTO CYTOSOL |
15 |
42 |
0.001889 |
0.007998 |
1100 |
MEMBRANE ORGANIZATION |
180 |
899 |
0.001903 |
0.008051 |
1101 |
REGULATION OF RESPIRATORY SYSTEM PROCESS |
8 |
16 |
0.001917 |
0.008073 |
1102 |
NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION |
8 |
16 |
0.001917 |
0.008073 |
1103 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
8 |
16 |
0.001917 |
0.008073 |
1104 |
POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY |
8 |
16 |
0.001917 |
0.008073 |
1105 |
MEGAKARYOCYTE DEVELOPMENT |
8 |
16 |
0.001917 |
0.008073 |
1106 |
POSITIVE REGULATION OF JUN KINASE ACTIVITY |
20 |
63 |
0.001927 |
0.008107 |
1107 |
MUCOPOLYSACCHARIDE METABOLIC PROCESS |
30 |
108 |
0.001943 |
0.008165 |
1108 |
PROSTATE GLAND MORPHOGENESIS |
10 |
23 |
0.002 |
0.008361 |
1109 |
RESPONSE TO AUDITORY STIMULUS |
10 |
23 |
0.002 |
0.008361 |
1110 |
MATING BEHAVIOR |
10 |
23 |
0.002 |
0.008361 |
1111 |
REGULATION OF RESPIRATORY GASEOUS EXCHANGE |
10 |
23 |
0.002 |
0.008361 |
1112 |
RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE |
10 |
23 |
0.002 |
0.008361 |
1113 |
MULTI ORGANISM REPRODUCTIVE BEHAVIOR |
10 |
23 |
0.002 |
0.008361 |
1114 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
49 |
200 |
0.002011 |
0.008401 |
1115 |
SMOOTHENED SIGNALING PATHWAY |
22 |
72 |
0.002039 |
0.008511 |
1116 |
POSITIVE REGULATION OF INFLAMMATORY RESPONSE |
31 |
113 |
0.002047 |
0.008533 |
1117 |
SYNAPTIC VESICLE CYCLE |
26 |
90 |
0.00207 |
0.008625 |
1118 |
AMINOGLYCAN METABOLIC PROCESS |
42 |
166 |
0.002135 |
0.008887 |
1119 |
REGULATION OF INTERLEUKIN 6 PRODUCTION |
29 |
104 |
0.002148 |
0.008933 |
1120 |
REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN |
7 |
13 |
0.002165 |
0.008953 |
1121 |
REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NEUROLOGICAL SYSTEM PROCESS |
7 |
13 |
0.002165 |
0.008953 |
1122 |
PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
7 |
13 |
0.002165 |
0.008953 |
1123 |
LEUKOCYTE TETHERING OR ROLLING |
7 |
13 |
0.002165 |
0.008953 |
1124 |
LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL |
7 |
13 |
0.002165 |
0.008953 |
1125 |
REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING |
7 |
13 |
0.002165 |
0.008953 |
1126 |
POSITIVE REGULATION OF CYTOKINE PRODUCTION |
82 |
370 |
0.002172 |
0.008975 |
1127 |
EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
18 |
55 |
0.002179 |
0.008988 |
1128 |
ACTIN CYTOSKELETON REORGANIZATION |
18 |
55 |
0.002179 |
0.008988 |
1129 |
REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN |
21 |
68 |
0.002206 |
0.009091 |
1130 |
REGULATION OF EXOCYTOSIS |
46 |
186 |
0.00222 |
0.00914 |
1131 |
NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
27 |
95 |
0.002228 |
0.009156 |
1132 |
CANONICAL WNT SIGNALING PATHWAY |
27 |
95 |
0.002228 |
0.009156 |
1133 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
51 |
211 |
0.002246 |
0.009215 |
1134 |
SKIN DEVELOPMENT |
51 |
211 |
0.002246 |
0.009215 |
1135 |
REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION |
11 |
27 |
0.002264 |
0.009242 |
1136 |
DEVELOPMENTAL INDUCTION |
11 |
27 |
0.002264 |
0.009242 |
1137 |
CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES |
11 |
27 |
0.002264 |
0.009242 |
1138 |
NEGATIVE REGULATION OF AXON GUIDANCE |
11 |
27 |
0.002264 |
0.009242 |
1139 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
11 |
27 |
0.002264 |
0.009242 |
1140 |
SUBSTRATE DEPENDENT CELL MIGRATION |
11 |
27 |
0.002264 |
0.009242 |
1141 |
POSITIVE REGULATION OF DNA REPLICATION |
25 |
86 |
0.002274 |
0.009263 |
1142 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
23 |
77 |
0.002272 |
0.009263 |
1143 |
NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
17 |
51 |
0.002294 |
0.009329 |
1144 |
CELLULAR RESPONSE TO FATTY ACID |
17 |
51 |
0.002294 |
0.009329 |
1145 |
RESPONSE TO RADIATION |
90 |
413 |
0.002315 |
0.009409 |
1146 |
NEGATIVE REGULATION OF TRANSPORTER ACTIVITY |
20 |
64 |
0.002378 |
0.009654 |
1147 |
REGULATION OF IMMUNE EFFECTOR PROCESS |
92 |
424 |
0.002384 |
0.009672 |
1148 |
ORGANIC ANION TRANSPORT |
85 |
387 |
0.002388 |
0.009678 |
1149 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
43 |
172 |
0.002435 |
0.00986 |
1150 |
SPHINGOLIPID METABOLIC PROCESS |
36 |
138 |
0.002453 |
0.009924 |
1151 |
CELL FATE DETERMINATION |
15 |
43 |
0.002467 |
0.009975 |
1152 |
HIPPOCAMPUS DEVELOPMENT |
22 |
73 |
0.002475 |
0.009987 |
1153 |
REGULATION OF PLASMA MEMBRANE ORGANIZATION |
22 |
73 |
0.002475 |
0.009987 |